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ABSTRACT 
 
Elucidating the Effects of Interstitial Fluid Flow on Hepatocellular Carcinoma Invasion 
Arpit D. Shah 
Adrian C. Shieh, Ph.D. 
 
 
 
 
Over the last two decades with advancements in research, detection, and treatment 
of all cancer types in the United States, resulting in an overall 23% decrease in cancer 
related deaths, liver cancer has gone against this trend possessing an increased death rate.  
Globally, hepatocellular carcinoma (HCC), the most common form of liver cancer, ranks 
as the second leading cause of cancer related deaths with approximately 788,000 deaths 
annually.  In recent years much emphasis has been placed on understanding the process of 
HCC cell invasion; however, it has become apparent that the progression of this disease is 
not solely dependent on just the cancer cells or biological factors, but also their interaction 
with the tumor microenvironment.  A significant number of studies have shown that 
changes in biomechanical forces within the tumor microenvironment can alter cancer 
progression.  Previous research has demonstrated that interstitial fluid flow (IFF), one of 
the biomechanical forces that is altered during tumor growth, can promote cancer cell 
invasion.  The findings in this work elucidate the effects of IFF in HCC cell invasion.   
 Using our 3D in vitro flow invasion assay, we demonstrate that IFF increases 
cellular invasion through autologous gradient formation of chemokines 
(CXCR4/CXCL12) that promote migration, a mechanism known as autologous 
chemotaxis.  We also demonstrated that MEK/ERK signaling affects IFF-induced 
invasion; however, this pathway was separate from CXCR4/CXCL12 signaling. Increased 
matrix metalloproteinase (MMP) expression is a hallmark for cancer progression and poor 
xvii 
 
 
prognosis.  Biomechanical forces have been observed to increase the secretion of these 
proteolytic enzymes, which promote extracellular matrix degradation and tumor cell 
invasion.  We observed an increase in MMP-9 and MMP-2 activity in HCC cells exposed 
to IFF.  In total these findings indicate multiple mechanisms are at play in HCC flow-
induced invasion, further emphasizing the significance biomechanical forces play in 
disease progression.    
 Finally, by modifying our 3D in vitro flow invasion assay, we examined IFF in a 
relevant cell-based disease model where HCC cells are embedded in a stiff matrix.  The 
increase in matrix stiffness is a result of tumor growth, shown to disturb the mechanical 
forces and biochemical signaling that occurs in the microenvironment, effectively 
promoting disease progression.  HCC also possesses a very unique disease profile and risk 
factors; nearly 80% of HCCs occur from patients who suffer from chronic fibrosis or 
cirrhosis, where inflammation and hepatic wound-healing response attributes to the 
hepatocarcinogenesis.  Many studies have observed cellular behavior of hepatocytes and 
HCC cells in a stiff matrix; however, none have observed the effect of IFF and a stiff 
microenvironment in HCC cells.  The findings in this chapter confirm a synergistic 
relationship between IFF and matrix stiffness on HCC cell invasion.  Ultimately the 
findings in this study provide a better foundational and mechanistic understanding of IFF 
and its effects on HCC cell invasion adding to the mounting evidence of how 
biomechanical forces in the tumor microenvironment influence cancer progression. 
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INTRODUCTION 
 
In recent years much emphasis has been placed on understanding the process of 
hepatocellular carcinoma (HCC) invasion; however, it has become apparent that the 
progression of this disease is not solely dependent on just the cancer cells or biological 
factors, but also the tumor microenvironment (TME).  A significant number of studies have 
shown that changes in biomechanical forces within the tumor microenvironment can alter 
cancer progression.  Previous research has demonstrated that interstitial fluid flow (IFF), 
one of the biomechanical forces that is altered during tumor growth, can promote cancer 
cell invasion.  The findings in this dissertation provide greater insight into understanding 
the effects of IFF in HCC cell invasion.  
This dissertation is organized into five main chapters.  The first chapter provides a 
thorough background and literature review on the etiology and development of HCC, 
followed by a discussion on the TME, IFF, and finally the mechanisms of IFF 
mechanosensing.  The proceeding three chapters contain findings and observations 
uncovered in this study highlighting the effects of IFF on HCC invasion.  In Chapter 2, the 
3D invasion assay was utilized with multiple HCC cell lines, which resulted in a greater 
invasive response to fluid flow.  I also uncovered higher fluid flow velocities correlate with 
HCC cell invasion, which could serve as a prognostic marker for HCC progression since 
elevated fluid flow velocity has been correlated with poor prognosis in many other cancers.  
Furthermore in Chapter 2 I uncovered autologous chemotaxis via the CXCR4/CXCL12 
signaling axis as a mechanism for flow-induced HCC invasion.  In the process I determined 
that MEK/ERK signaling is also required in flow-induced HCC cell invasion, but was 
independent of the autologous chemotaxis mechanism.  In Chapter 3, I describe how the 
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proteolytic activity of MMP-9 and MMP-2 is increased when HCC cells are exposed to 
IFF, while MMP-2/9 expression does not change.  Furthermore we confirmed that this 
elevated MMP-9 and MMP-2 activity is independent of the autologous chemotaxis 
mechanism, suggesting multiple mechanisms could be driving IFF-induced invasion of 
Huh7 cells.   
Chapter 4 observed the effects of IFF in a physiological disease relevant HCC cell 
based model where HCC cells are embedded in a stiff matrix.  The increase in matrix 
stiffness as a result of tumor growth, shown to disturb the mechanical forces and 
biochemical signaling that occurs in the microenvironment, effectively promoting disease 
progression.  HCC also possesses a very unique disease profile and risk factors; nearly 80% 
of HCCs occur in patients who suffer from chronic fibrosis or cirrhosis where inflammation 
and hepatic wound-healing response attributes to the hepatocarcinogenesis.  Many studies 
have observed cellular behavior of hepatocytes and HCC cells in a stiff matrix; however, 
none have observed the effect of IFF and a stiff microenvironment in HCC cells.  The 
findings in this chapter confirmed a synergistic relationship between IFF and matrix 
stiffness on HCC cell invasion.   
 Finally, Chapter 5 discussed the main findings from this work and the significance 
in uncovering multiple mechanisms and signaling pathways that can regulate flow-induced 
HCC cell invasion.  This work contributes to the mounting evidence of how biomechanical 
forces in the TME influence cancer progression. 
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CHAPTER 1: BACKGROUND 
†Portions of this chapter were published in the book, ‘Cells, Forces, and the Microenvironment’: Shah, A., & 
Shieh, A. (2015). Interstitial Fluid Flow Mechanosensing: Mechanisms and Consequences Cells, Forces, and 
the Microenvironment (pp. 127-154): Pan Stanford 
 
1.1 Hepatocellular carcinoma 
Cancer is a complex multi-step disease that occurs when abnormal cells divide in a 
dysregulated fashion.  Cancer cells continuously divide and many times begin to show 
invasive characteristics; these cells are capable of dislodging themselves from a primary 
tumor site and eventually metastasizing to another tissue site via the lymphatic system or 
the bloodstream [1].  Consequently, a majority of cancer related deaths are due to the 
uncontrolled proliferation and invasive nature of these cancer cells.  The World Health 
Organization estimates 1 in 6 deaths are due to cancer, making it the second leading cause 
of death worldwide.  Hepatocellular carcinoma (HCC) is the most common form of liver 
cancer, which is the second leading cause of cancer-related deaths estimated by the World 
Health Organization with over 788,000 deaths annually.  In the United States, liver cancer 
has tripled in incidence since 1980, and it is estimated that there will be 40,710 new cases 
of liver cancer with 28,920 deaths in 2017 [2].  It is important to note that over the last two 
decades there have been significant advancements in research, detection, and treatment of 
all cancer types in the United States, resulting in an overall 23% decrease in cancer related 
deaths, but liver cancer has gone against the trend, with an increased death rate of 3% per 
year since 2000 [2].  Treatment of HCC remains a challenge, with 5 year survival rates for 
patients with stages IIC and IVA (regional HCC) of 10% and for patients with stage IVB 
(distant HCC) as low as 3% [3].  At the present time, the natural history of HCC is not well 
pronounced until it is diagnosed as it has been observed to be clinically indolent in its 
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infancy; notably there is a severe dearth of knowledge in the mechanism of hepatocytes 
transitioning to a neoplastic state, often attributed to its diverse risk profile [4, 5].   
The high mortality rate in patients with HCC is attributed to undetected tumor 
progression and the formation of metastases, which is encouraged by underlying chronic 
liver disease [4].  Chronic hepatitis B (HBV) and C virus infection account for nearly 85% 
of HCC cases worldwide, primarily occurring in countries lacking HBV vaccination 
programs such as sub-Saharan Africa and southeast Asia [6, 7].  Cirrhosis is a major 
contributor in the progression of HCC; however, it is not only observed in patients who 
suffer from chronic viral hepatitis, but also from patients who suffer from type 2 diabetes, 
alcoholism, and non-alcoholic fatty liver disease often observed in developed countries [4, 
8, 9].  Chronic hepatitis and metabolic disorders are not the only risk factors associated 
with the development of HCC; many other unique risk factors have been identified over 
the years (Figure 1) [4].  Due to the diverse risk profile associated with HCC, there is a 
lack of screening for the general population, making early detection and diagnosis very 
difficult.  
 
Figure 1: Distribution of risk factors associated with development of hepatocellular 
carcinoma.   
Chronic Hepatitis B Virus 
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Virus (HCV), 31%
Other, 15%
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Aflatoxin-B1 intoxication 
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Alpha1 anti-trypsin 
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Genetic predisposition 
Anabolizing hormones 
Estrogen contraceptives 
Obesity 
Type II diabetes 
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Metabolic syndrome 
Hypothyroidism 
Fatty liver 
Non-alcoholic steato-
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1.2 Normal liver function and hepatocellular carcinoma development 
 
 The liver has two major functions: 1) synthesis, metabolism, and clearance of 
protein and various chemicals and 2) secretion of bile for waste removal.  Liver function 
is often compromised during the transition to HCC where the dysregulation of hepatocytes 
to HCC cell proliferation is thrown off balance.  To date many risk factors associated with 
the development of HCC have been identified and studied (Figure 1); however, the exact 
mechanisms of the transition from normal healthy hepatocytes to malignant neoplasms 
have not been elucidated.  Chronic HBV infection is the most common cause of HCC as 
the virus genome possesses four overlapping open reading frames where the partially 
double-stranded DNA encodes the viral envelope, preCore, core, polymerase, and HBx 
proteins [10, 11].  The most common characteristic observed during chronic liver injury is 
the continuous cycle of cell death and regeneration that is often a result of inflammation.  
In the event of HCV which is an RNA virus that replicates in hepatocyte cytoplasm’s with 
a rapid virus turnover and spreading from one cell to the next [12].  Both of these viruses 
are leading causes for chronic liver disease and the eventual progression to HCC.  
Additionally, alcohol-induced hepatocarcinogenesis, where the consumption of alcohol in 
large volumes results in production of proinflammatory cytokines and prolonged 
circulation of endotoxins.  Often the transition of a healthy liver to the development of 
HCC by either viral or alcohol-induced hepatocarcinogenesis is accompanied by cirrhosis 
of the liver and ultimate loss of function by this vital organ [13, 14].  The development of 
HCC is often a slow one over the course of decades for most patients who suffer from any 
chronic liver injury.  Accordingly similarities in signaling pathways involved HCC 
development have been identified and implicated in underlying liver disease: Ras and 
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Raf/MEK/ERK, PI3K/AKT/mTOR, and WNT/β-catenin.  Additionally with the use of 
integrative transcriptome analysis, 3 molecular subclasses of HCC have been identified 
from analysis of 603 patients with HCC.  The first subclass, S1, possessed a distinct 
activation of WNT.  The second subclass, S2, upon analysis possessed HCCs with 
proliferative characteristics via AKT activation, and the S3 subclass was related more 
towards hepatocyte differentiation [15].  
 
 
 
 
Figure 2: Biological multi-step process of hepatocellular carcinoma development.  
(Adaptation of Figure 2 from Cetin-Atalay et al 2015 [16]) 
 
 
  
The Ras/Raf/MEK/ERK signaling cascade is a popular therapeutic target for 
treating HCC as it has been shown to be constitutively activated; in other solid tumors 
components from this pathway have been shown to be overexpressed or activated resulting 
in tumorigenesis, disease progression, and metastasis of the cancer [17, 18].  In primary 
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liver cancer HBV X protein (HBx) integration is involved in the transformation process of 
malignant HCC [19].  This viral protein is also shown to activate the Ras/Raf/MEK/ERK 
signaling pathway where they cohesively alter regulation of cell cycle check points as well 
as activate of several oncogenes in the cytoplasm [20-22].  The Ras/Raf/MEK/ERK 
pathway has been shown to be activated by a multitude of upstream receptor tyrosine 
kinases (RTKs)  such as epidermal growth factor receptor (EGFR), platelet-derived growth 
factor receptor (PDGFR), and vascular endothelial growth factor receptors (VEGFR)  [23].  
Nearly 30% of HCCs possess a Ras mutation resulting in downstream activation of the 
critical molecular signaling regulator Raf; more specifically one of its three isoforms: 
ARAF, BRAF, or CRAF [24].  Ras/Raf signaling has been shown to be a critical pathway 
in sustaining proliferation aiding in the development of HCC [25].  Constitutively elevated 
MEK/ERK activity has been observed in HCC cells, HCC tissue, as well as other 
carcinomas resulting in altered cell proliferation, differentiation, and apoptosis [26, 27].    
 Similar to Ras/Raf/MEK/ERK signaling cascade, the PI3K/AKT/mTOR pathway 
has been observed to be constitutively activated in many solid tumors often playing a 
critical role in tumor cell growth, proliferation, and survival [28].  In HCC, 30-50% of all 
HCCs possess activated PI3K signaling, and this signaling cascade is often over activated 
by receptor tyrosine kinases such as insulin growth factor (IGF) receptors often observed 
in cirrhotic livers [29, 30].  In turn this activated PI3K signaling cascade can 
simultaneously activate Raf/MEK/ERK and the WNT/β-catenin signaling cascades [30, 
31].  The PI3K signaling cascade in HCC has been observed to be activated due to 
abnormal phosphatase and tensin homolog (PTEN) function while during normal liver 
function, PTEN has been often observed to be negatively regulated [32].  The loss of PTEN 
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regulation with overexpression of pAKT and p-mTOR in some cases has been shown to 
result in HCC tumor differentiation, intrahepatic metastasis, and MMP-2/9 upregulation 
[32-34].  Notably, mTOR signaling is disrupted by the over activation of PI3K/AKT in 
HCC resulting in increased cell proliferation [35].   
Activation of the WNT/β-catenin signaling pathway has been observed to play an 
important role in some early carcinogenic events in HCC development via abnormal 
regulation of the transcription factor β-catenin [36].  In normal physiology, the WNT 
signaling cascade is responsible for various cellular process such as homeostasis, cell 
proliferation, differentiation, motility, and even cell apoptosis [37].  Early HCC due to 
HBV, HCV, and alcoholic liver cirrhosis in some cases has been observed to possess WNT 
activation due to a β-catenin mutation [38].  In cases of HCCs directly caused by chronic 
HCV infection approximately, 50-70% of tumors possessed greater β-catenin levels in the 
cytoplasm [39, 40].  This increased WNT activity and increased activated β-catenin in the 
cells has been correlated to increased invasion and metastatic potential [41].  
 
 
1.3 Tumor microenvironment in hepatocellular carcinoma progression 
 
 A significant body of literature has demonstrated the importance of investigating 
the liver tumor microenvironment (TME). These studies have highlighted that the cross-
talk between tumor cells and the surrounding stroma plays a key role in HCC progression, 
EMT, tumor growth, invasion, and metastatic spread [42, 43].  Investigating the cellular 
and non-cellular components within the TME of the liver has resulted in a better 
understanding of HCC progression and the mechanisms involved, and has also provided 
physicians with a better understanding of HCC tumor progression, staging, and therapeutic 
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strategies [42, 44, 45].  Notably investigating the TME of HCC is often a difficult one as 
most HCCs develop in the presence of chronic liver injury adding to the complexity of 
studying the ever-changing TME and malignancy.  
Many studies have shown that chronic liver injury promotes the development of 
fibrosis and cirrhosis and this eventually progresses to HCC [46-48].  The mechanical and 
molecular events that occur during fibrosis, scarring of the liver, essentially provide a pro-
carcinogenic effect in the liver microenvironment.  There have been a variety of risk factors 
identified for liver fibrosis such as metabolic syndrome/fatty liver disease and even heavy 
alcohol consumption.  However to date, untreated chronic viral infections such as hepatitis 
B and C are the two greatest risk factors for development of liver fibrosis [48].   
The ECM of the liver plays a significantly dynamic role in liver function. The ECM 
proteins mechanically play an important role in the liver by providing tensile strength and 
resilience.  From an architectural standpoint these ECM proteins can alter diffusive 
properties and  regulate  cellular movement [49].  In liver fibrosis, the increased production 
and accumulation of ECM proteins is the hallmark response to this acute injury in order to 
protect the parenchymal cells.  Dysregulation of this balanced response within the liver 
disrupts normal healthy function and this excessive accumulation of ECM proteins is often 
regarded as an indicator of a pathological state [49-51].  A complex set of mechanical and 
molecular events occur during hepatic fibrosis; initially a wound-healing response occurs 
in the presence of an acute liver injury.  On a cellular level this wound-healing response 
results in an initial response from inflammatory lymphocytes which infiltrate the 
parenchyma of the liver [52, 53].  Simultaneously regeneration of parenchymal cells occurs 
in order to replace any apoptotic hepatocytes and activation of Kupffer cells which 
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modulate proinflammatory and fibrogenic mediators like TNF-α and IL-6 shown to 
regulated hepatocyte survival [13, 54-57].  HSCs found in the perisinusoidal space of Disse 
make up nearly 10% of all cells in the liver and serve as the primary source of ECM 
proteins, where once they are activated, these cells help coordinate the repair efforts of the 
injury site [51, 58-60].  In a persistent chronic injury state from viral infections like HBV 
or HCV, the activated HSCs transdifferentiate into myofibroblast-like cells and continue 
to deposit fibrillar and non-fibrillar collagens along with other ECM proteins by migrating 
to the injured sites [61].  These cells acquire proinflammatory and fibrogenic properties, 
ultimately resulting in dysregulated ECM degradation and continuous fibrillar collagen 
deposition over hepatocytes, thus distorting liver function and architecture [56, 59, 60].  
Soluble factors such as inflammatory cytokines and growth factors like, TNF-α and TGF-
β, contribute and help maintain the activated fibrogenic state and perpetuate a reciprocating 
relationship between inflammatory and fibrogenic cells [62].   
The accumulation of these ECM proteins has been shown to alter the availability 
of soluble factors which in turn affects cellular functions such as cell growth, survival, 
adhesion, migration, and even differentiation [63-65].  As discussed previously, fibrosis in 
the liver results in changes to the physical architecture of the tissue, notably the increased 
accumulation of ECM proteins (eight-fold higher than healthy livers) has been shown to 
alter the hepatocyte microenvironment and cell behavior [66].  The increased accumulation 
of ECM proteins results in a remodeled matrix that is much stiffer.  A variety of normal 
cell types are capable of observing and responding to changes in stiffness within their 
microenvironment; the mechanosensing of this specific environmental change occurs 
through many different mechanisms often altering the balance of mechanical forces and 
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molecular signaling in turn effecting cell behavior [67].  Furthermore, the transformed 
ECM functions as a reservoir for various growth factors and proteolytic enzymes like 
MMPs, which have been shown to aid differentiation of hepatocytes to HCCs [68, 69] 
The cross-talk between the cellular and the non-cellular components such as 
cytokines, growth factors, ECM proteins, and proteolytic enzymes play a substantial role 
in HCC progression.  Understanding the interplay between these components and the 
altered biomechanical forces in the TME could lead to the identification of new and 
effective treatment options.     
 
1.3.1 Cellular components 
 
Cancer-associated fibroblasts  
Cancer-associated fibroblasts (CAFs), activated by TGF-β, are located in the tumor 
stroma and play a critical role in ECM protein deposition and remodeling which attribute 
to metastatic spread [70].  Tumor-stromal interactions often involve CAFs and HCC cells 
which have been shown to possess a reciprocating relationship where the presence of 
CAFs, promotes HCC cell growth and in turn these malignant cells aid in proliferation of 
CAFs [71].  Additionally CAFs promote tumor progression with the production of growth 
factors like EGF, HGF, FGF; chemokines such as stromal-derived factor-1α (SDF-1α); and 
cytokines such as interleukin-6 (IL-6), and interleukin-8 (IL-8) [35, 72-74].   
 
Hepatic stellate cells 
As previously discussed, the development of HCC is often in the presence of 
underlying chronic liver injury such as fibrosis, and quiescent hepatic stellate cells (HSCs) 
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are activated by this repeated liver injury [75].  Located in the Space of Disse of the liver, 
HSCs, also known as peri-sinusoidal or Ito cells, are activated in the presence of repeated 
liver injury, hepatic toxins, or viral infections, and play a vital role in fibrosis development 
where they are responsible for collagen synthesis and trans-differentiate into 
myofibroblast-like cells [51, 76].  Upon activation, HSCs experience a phenotypic 
transformation where they increase proliferation, secretion of ECM proteins, production 
various cytokines, chemokines, and growth factors [46, 51, 52, 77, 78].  Dormant HSCs 
protect the liver when it is damaged by hepatic toxins or a viral infection in their activated 
state by secreting cytokines, growth factors, and ECM proteins [77].  It is important to note 
that this response form HSCs is due to chronic liver injury; the activated HSCs possess the 
ability to penetrate the stroma and settle around the liver sinusoids, fibrous septa, and 
capsules of the tumor [79, 80].  Furthermore, these activated HSCs play a prominent role 
in hepatic immune responses as they are capable of suppressing the immune response of 
monocytes during inflammation and promoting HCC cell growth [81-83].  Activated HSCs 
in the tumor microenvironment induce HCC cell proliferation and migration (via NF-κB 
and ERK), and ultimately tumor growth, enhancing HCC progression and poor clinical 
outcomes [82].    
 
Tumor-associated endothelial cells 
The vascular endothelium is comprised of blood vessels that aid in the transport of 
nutrients found in blood to the tissues in the body.  These blood vessels are comprised of 
tightly formed continuous monolayers of endothelial cells, which in normal healthy tissues 
can express angiogenic receptors and C-X-C chemokine receptors [84-88].  Binding of 
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these ligands to their respective angiogenic and chemokine receptors affects the signaling 
cascade that regulates cellular functions such as survival, proliferation, and migration [88-
90].  Additionally, it is important to note that the liver is one of the most vascular organs 
in the body and HCC is one of the most vascular solid tumors.  Furthermore, these 
endothelial cells behave much differently in HCC tissues compared to normal tissue, and 
as a result endothelial cells found in the TME are referred to as tumor-associated 
endothelial cells [91].  Tumor-associated endothelial cells behave and function much 
differently than normal endothelial cells as they are observed to possess rapid cell turn 
over, increased TGF-β1expression, and dysregulation of cellular functions like survival, 
proliferation, and invasion [92-94].  These tumor-associated endothelial cells are observed 
to possess irregular morphology and variation in size which results in the formation of 
leaky blood vessels within the tumor [95].  Many human HCC cases have been observed 
to possess increased upregulation of VEGF expression which promotes tumor progression 
by increasing angiogenesis via tumor endothelial cells [89, 96, 97].       
 
1.3.2 Non-cellular components 
 
The TME is a complex environment in which the tumor and surrounding cellular 
components interact in a reciprocating manner activating various signaling pathways 
resulting in dysregulated cellular processes.  However, this is a very complex process 
where the non-cellular components in the tumor microenvironment assist in the growth and 
sustainability of the tumor and the eventual loosening and degradation of the tumor cell 
from the ECM.  Chemoattractants provide chemical signaling cues to the cell, where these 
tumor cells’ invasive nature result in their eventual spread to another organ [90].  This 
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spreading or progression of the tumor cells to a secondary site is not possible without the 
non-cellular components such as cytokines and growth factors, which serve to help tumor 
cells evade immune cells, but also allow for sustained growth [98-100].  ECM proteins and 
MMPs serve as non-cellular components which play a significant role in the migration and 
invasion of the tumor cells [101, 102].   
 
Cytokines  
Researchers over the years have identified cytokines to be vital contributors HCC 
in the liver tumor microenvironment.  Most HCC cases in the liver arise from underlying 
chronic liver injury often in the presence of inflammation and scarring of the liver, and 
inflammatory cytokines are produced in response to this injury.  These cytokines have been 
observed to induce proliferation in various cell types and also contribute to the migration 
of tumor cells [103, 104].   Kupffer cells are liver macrophages that are capable of 
producing a variety of cytokines which regulate regenerative and proliferative processes in 
the liver by activating receptors found on hepatocytes.  In a malignant state, these receptors 
are often activated by a variety of cells altering, immune cell response to viruses and 
inhibiting apoptosis in cancer cells.  IL-6 is an inflammatory cytokine that is observed to 
be in the presence of hepatocyte death and also contributes to hepatocyte proliferation by 
Kupffer cells [105].  The increase in IL-6 in patients with cirrhosis is correlated with 
increased HCC and poor prognosis of individuals suffering from HCC [98, 105].  Tumor 
necrosis factor-alpha (TNF-α) is a prominent cytokine that is expressed in the presence of 
liver injury activating downstream NF-κB and Akt [106, 107].    Similar to IL-6, TNF-α is 
activated during inflammation, and studies show high expression levels are correlated to 
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HCC recurrence in patients [108, 109].  Various pro-inflammatory cytokines have been 
investigated and shown to play a role in HCC progression and can be produced by both 
cancerous and non-cancerous cells.  A robust review by Wang and colleagues has outlined 
in detail the role of cytokines in HCC progression or HBV/HCV associated HCC [110]. 
 
Growth factors 
 The interactions between the components of the microenvironment have been 
shown to often result in a pro-metastatic state; however, the molecular mechanisms 
involved are not fully elucidated.  Growth factors such as TGF-β, VEGF, HGF, FGF, and 
PDGF play an indispensable role in regulating cell processes and tumor progression [46, 
92, 111-115].  Before the development of HCC, TGF-β plays the role of a tumor suppressor 
by regulating apoptotic signals to modulate proliferation through TGF-β1 [116, 117].  
TGF-β plays a vital role in liver fibrogenesis and hepatocarcinogenesis as it has been shown 
to be up-regulated in liver tissue with HCC and peri-neoplastic stroma [117, 118].  The 
presence of the HBx protein and even HCV have been shown to shift TGF-β signaling from 
its tumor-suppressive state to an activated state via c-Jun N-terminal kinase (JNK) [112, 
119].  Due to the vascular nature of HCC, VEGF has been observed to be a critical growth 
factor stimulating angiogenesis by promoting proliferation of endothelial cells to drive 
HCC progression [114].  Tumor-stromal interactions are mediated by HGF expressed by 
HSCs and have been shown to increase HCC cell proliferation and invasion [114].         
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Extracellular matrix proteins  
The ECM is analogous to a structural scaffold as it provides physical support and 
anchorage sites for parenchymal and non-parenchymal cells.  The ECM and the proteins 
that comprise it are no longer recognized as passive components in cancer progression.  
Collagen is the most abundant ECM protein in the liver; activated HSCs have been 
identified to be the main cellular source for collagen [120].  This fibrillar protein provides 
structural support for cells, but in the presence of chronic liver injury, collagen is 
overexpressed resulting in a stiff matrix.  In HCC, collagen can promote cell migration and 
proliferation [121].  Laminins are ECM proteins that form web-like structures to mediate 
tensile forces that occur in the basal lamina via basement membrane assembly.  Laminin is 
also involved in cellular processes like cell migration, growth, and differentiation [122].  
In HCC, lamin-5 is found in HCC nodules and expressed in HCCs associated with a 
metastatic phenotype [123].  Integrins are found on cell surfaces serving as heterodimeric 
transmembrane receptor proteins mediating cell adhesion.  To date, there are more than 20 
different integrin heterodimers, but specific integrin subunits have been identified to 
mediate cellular processes in HCC cells [124].  The β3 subunit has been found to play a 
role in cell growth and apoptosis while the overexpression of integrins with the β1 subunit 
inhibit HCC cell proliferation, migration, and invasion [125-127].  Proteoglycans are found 
in the ECM and play a vital role in intracellular communication, maintain the ECM 
framework, and serve as a reservoir for growth factor storage.  Heparan sulfate 
proteoglycans are involved in the pathogenesis of HCC by storing growth factors (FGF, 
HGF, PDGF, and VEGF) which have been shown to contribute to HCC progression [46, 
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113, 114, 128].  The ECM proteins described here play a critical role in regulating various 
cellular process and ultimately promoting HCC progression.  
 
Matrix metalloproteinases  
 MMPs play a central role in mediating changes to the tumor microenvironment 
through various physiological processes and signaling events.  Since their discovery in 
1962, a total of 23 different MMPs have been identified in humans and have been 
investigated as therapeutic targets for treating cancer and inflammatory diseases [129, 130].  
Various tumor and stromal cells  are capable of producing these MMPs, which have been 
categorized into the following subtypes based on their domain structure and function: 
collagenases (MMP-1/8/13), gelatinases (MMP-9/2), matrylisins (MMP-7/26), membrane 
type MMPs (MMP-14/15/16/17/24/25), and stromelysins (MMP-3/10/11) [131].  These 
proteolytic enzymes function as integral communicators between the tumor and stroma to 
drive tumor progression.  MMPs degrade the structural frame work of the ECM creating 
an escape route for tumor cells to migrate, thus their elevated expression is often correlated 
with poor prognosis in cancer [132].  MMPs are expressed in an enzymatically inactive 
state due to the presence of an unpaired cysteine residue at the C-terminal end of the pro-
domain and a zinc ion found in the catalytic or active-site.  These zinc-dependent 
endopeptidases become proteolytically activate by a mechanism known as the cysteine 
switch, where the pro-domain is removed or the cysteine residue chemically modified, 
allowing the active-site to cleave substrates [133].  Proteolytic activity of MMPs can be 
regulated at various levels from gene expression, zymogen conversion, extracellular 
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activation by activated MMPs, presences of serine proteinases, localization on cell 
surfaces, or even by endogenous inhibitors like TIMP [134].   
 In the TME, MMPs not only aid in the remodeling of the hepatic architecture, but 
play key roles in pro- and anti-inflammation, tumor cell growth, invasion, and metastasis 
[90].  The expression of the gelatinases (MMP-9 and MMP-2) have been correlated to 
increased HCC invasion and pathological parameters like tumor size, stage, and probability 
of HCC recurrence [135-137].  In HCC, MMP-9 and MMP-2 have been observed to 
regulate chemokine and cytokine recruitment in response to inflammation, bioavailability 
of VEGF for angiogenesis, and modulate EMT by activating TGF-β1, resulting in HCC 
tumorigenesis [99, 138, 139].  Inhibition of these active MMPs is regulated by TIMPs 
which prevent excessive degradation of the ECM, but also regulate cell proliferation, 
apoptosis, and the activation of MMPs.  The balance between TIMPs and the gelatinases 
is tightly regulated and any dysregulation of this relationship has been observed to result 
in detrimental outcomes in HCC [32, 140]. 
 
1.4 Basics of interstitial fluid flow† 
 
Interstitial fluid flows through intercellular spaces of the extracellular matrix 
between blood and lymphatic capillaries, where it is eventually collected and drained by 
the lymphatic system as lymph [141, 142].  Convective forces facilitate transport of 
molecules while simultaneously maintaining tissue fluid balance [142]. This fluid flow 
through the interstitium also generates biophysical forces that may directly affect cells 
[143].  Theoretical or computational models of interstitial flow are complicated by the 
nature of interstitial flow; at each location in the interstitium where fluid flow occurs, the 
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structure and properties of the matrix can vary considerably, along with the shape and 
orientation of affected cells.  However, despite these complexities, several governing 
principles can be considered to better understand IFF in a quantitative fashion. 
 
1.4.1 Interstitial flow velocity 
 
One of the fundamental ways to characterize fluid flow is by the velocity.  In the 
case of interstitial flow, there have been a number of experimental measurements and 
computational models to estimate flow velocity in vivo.  Utilizing the technique, 
fluorescence recovery after photobleaching (FRAP), resulted in a IFF velocity range of 0.1 
- 2 µm/s in a rabbit ear chamber with bovine serum albumin conjugated with fluorescein 
isothiocyanate tracer [144].  An in vivo study examined the effect of overexpression of 
VEGF165 and its role on peritumoral fluid convection and lymphatic drainage.  Magnetic 
resonance imaging (MRI) of the VEGF165-overexpressing tumors revealed IFF velocities 
of approximately 0.2 - 0.3 µm/s.  Overall there was increased interstitial convection, 
vascular permeability, and lymphatic drainage in tumors [145]. Dynamic contrast-
enhanced MRI (DCE-MRI) has also been used to measure fluid-flow velocity at the edge 
of cervical carcinoma xenografts in mice and cervical tumors in humans by wash out of 
gadolinium-based contrast agents.  Flow at the tumor edge is of particular interest, since 
there is dramatic gradient in fluid pressure between the high pressure tumor and the lower 
pressure surrounding tissue.  This pressure gradient resulted in an approximated flow 
velocity of 5 µm/s  at an interstitial fluid pressure of 20 mmHg in mouse xenografts, while 
human cervical cancer patients with pelvic lymph node metastases showed flow velocities 
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as high as 50 µm/s [146].  Other models have shown that the periphery of a tumor can have 
interstitial-fluid velocities as high as 10 µm/s as well [147].   
To date there is much uncertainty in regards to determining quantitatively the flow 
velocity, many of these studies correlate it to various parameters such as convective 
transport of macromolecules or shear stress that is generated on the cell surface.  Overall 
there are many challenges for current computational models and in vivo measurements of 
interstitial-flow velocities.  The internal forces and interstitial spaces of various tissues are 
highly heterogeneous, thus making it very difficult to determine the characteristics of 
interstitial flow without identifying and understanding all local parameters. Nevertheless, 
quantitatively determining flow velocity (and other flow characteristics) would provide a 
greater understanding of the effects interstitial flow may exert on cells and tissues. 
 
1.4.2 Starling’s Equation 
To characterize IFF, we need to first understand the phenomenon of capillary 
filtration.   It is widely known that oncotic (colloid osmotic) and hydrostatic pressure 
gradients play a major role in the movement of fluid.  In 1846, Ernest Henry Starling 
determined that forces such as tissue fluid pressure (Pt), capillary fluid pressure (Pc), tissue 
colloid osmotic pressure (πt), and plasma colloid osmotic pressure(πp), known as Starling 
forces, were responsible for driving capillary filtration [148, 149].  In humans, typical 
colloid osmotic pressure is 28 mmHg for the capillaries and 8 mmHg for the interstitium, 
while hydrostatic pressure is 20 mmHg for the capillaries and -1 to -3 mmHg for the 
interstitium [150].  Oncotic pressure is an important indicator for identifying potential 
diseases; elevated oncotic pressure is associated with pulmonary edema [151].  
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Additionally in cancer, studies in rats have shown that both oncotic and interstitial-fluid 
pressure are elevated in solid tumors [152].   
Using these hydrostatic and oncotic pressures, Starling’s equation predicts fluid 
filtration across capillary membranes: 
 = ,	
 − 
 − 	Π − Π 
Jv is the transcapillary fluid flow, Kf,c is the capillary filtration coefficient, and σ is 
the capillary protein reflection coefficient.  The reflection coefficient represents the degree 
to which the capillary is impermeable to the proteins generating the oncotic pressure 
gradient [153].  If the capillary was permeable to all plasma proteins, then the reflection 
coefficient would be 0, whereas a completely impermeable capillary would have a 
reflection coefficient of 1.  A majority of the fluid filtered through the capillary wall is 
reabsorbed by downstream post-capillary venules; however a small fraction of this fluid 
remains within the tissue interstitium [154, 155].  This fluid is ultimately converted into 
lymph once it is drained from the interstitium by the initial lymphatic capillaries.  However, 
while Starling’s equation describes capillary fluid filtration, it does not model interstitial 
flow within the tissue.  For this, we turn to civil engineering and models of flow through 
porous media. 
 
1.4.3 Darcy’s law and Brinkman’s equation 
IFF depends on many factors, such as pressure gradients within the interstitium and 
the structure and properties of the tissue.  Darcy’s Law was developed to characterize fluid 
flowing through a porous medium.  In 1856 Henry Darcy examined the flow of 
groundwater through sand-beds that assisted in filtration [155]:   
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The equation is comprised of ̅ , the bulk-averaged velocity; k, the permeability 
(measured in m2); µ, the fluid viscosity; and P, the fluid pressure [156].  Collagen gels have 
been shown to have permeability values ranging from 10-7 to 10-8 cm2, with gel 
permeability increasing with increasing culture time [157].  The permeability of gels made 
from Matrigel was found to be approximately 10-8 cm2 [158].   Tissue permeability ranges 
between 10-8 and 10-12 cm2 [141]. 
The equation that Darcy developed for one-dimensional flow is helpful in 
determining average flow velocity; however, it is not sufficient in understanding complex 
permeability and flow in tissues.  Brinkman’s equation was developed by Henry Brinkman 
in 1949,  when he modified Darcy’s equation to take into consideration changes in 
viscosity, viscous shear effects, and the presence of a boundary layer [143]:   

 =  − μ ̅ + μ̅ 
The Darcy-Brinkman equation helps characterize flow of fluid through porous 
media where fluid viscosity is factored in with boundary layer effects.  These fundamental 
equations allow for analysis of fluid flow through the interstitium due to pressure gradients 
that are developed.  However, these equations normally assume constant matrix 
permeabilities, and do not consider the heterogeneity in tissue structure and properties 
[159].  This can result in large local variations in interstitial flow.  Regardless of these 
limitations these two equations have helped create a fundamental understanding of how 
interstitial fluid flows through tissues.    
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1.4.4 Shear stress 
IFF generates direct stress on cells within a microenvironment along with indirect 
forces transmitted via the matrix [143].  These direct and indirect forces result in 
biochemical and biophysical cues that can lead to profound changes to the cell and its 
normal function [144, 154, 160-169].  Forces such as fluid shear stress are exerted on 
surfaces due to a tangential stress caused by fluid viscosity and flow [170].  However, the 
intensity of the shear stress is dramatically less on the cell due to extracellular matrix fibers 
that shield the cell from direct fluid shear [154].  Fluid shear stress that occurs on cells may 
be transmitted through structures such as the glycocalyx – an extracellular coat of 
glycoproteins, glycolipids, and proteoglycans that has been shown to transduce fluid flow-
induced shear stress in endothelial cells [171].   Given estimated interstitial flow velocities, 
it is generally assumed that the resulting shear stresses are comparatively low.   It has been 
hypothesized that interstitial flow can result in shear stresses of 0.1 dyne cm-2 or even 
lower; however this does not mean that they can be neglected [172].   Computational fluid 
dynamic simulations of flow through in vitro collagen gels have shown that maximum 
shear stresses are three times higher and average shear stress two times higher than values 
predicted by Brinkman’s equation [154].  Average shear stress can be calculated with 
consideration of high porosity matrices, cell profile, and fibers on the cell membrane [154]: 
 = 38 ∙
	!"μ#  ∙ $1 +
1
& 
The average shear stress is denoted by avg, free stream velocity is noted as U0, 
viscosity is µ, the cell radius is represented by a, and  is the dimensionless 
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permeability[154].  Shear stress plays a major role in triggering various biochemical signals 
[166, 173-178].  
 
1.4.5 Convective mass transport 
Convection has been examined in many models, from transport of fluid through 
sediment to convective transport in tumors [179, 180].  As noted earlier gradients created 
by interstitial pressure play a role in transcapillary exchange of fluid and macromolecules.  
The dimensionless Peclet number can be used to determine if convection can be neglected 
for mass transport in a particular setting or system.   The Peclet number is a dimensionless 
ratio that determines the relative importance of convective versus diffusive mass transport 
of a species, and is defined as the following:  

' = ()*+  
L is the characteristic length, )* is the bulk convective velocity of the solute, and 
+is the diffusion coefficient [156].  When 
'<<1 diffusion is the dominant form of 
transport, while for 
'>>1 convection is the driving force for transport.  The utilization of 
the Peclet number in the study showed that when there was a high Peclet ratio with 
increased velocities or decreased diffusion coefficients of secreted proteins, a biased 
transcellular gradient formed [181].  However, even at low Peclet numbers (less than 1), 
interstitial flow may still generate biologically relevant, asymmetric pericellular 
morphogen gradients [181].   
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1.5 Effects of interstitial flow in biological systems † 
 
Interstitial fluid flow plays a significant role in various physiological and disease 
systems.  This section highlights examples of the effects of IFF in three systems: blood 
vessels, lymphatic vessels, and cancer.  Blood and lymphatic vessels are constantly 
exposed to mechanical forces and IFF plays an important role in cellular behavior, 
signaling, lymphangiogenesis, and angiogenesis [170, 172, 182-185].  In cancer, IFF may 
cause reorganization of extracellular matrices and  promote tumor cell invasion mediated 
by autologous chemotaxis [186, 187].   
We would like to note that one system where IFF mechanotransduction has been 
extensively studied is in bone.  Unlike many other tissues described here, where interstitial 
flow is driven primarily by the pressure differences between blood capillaries, the 
interstitium, and lymphatic vessels, interstitial flow in bone occurs in response to external 
mechanical loading.  These external loads result in transient pressure gradients that drive 
dynamic and often oscillatory interstitial flow through the extensive lacunae-canaliculi 
network, simulating osteocyte and osteoblast cell processes.  There are many nuances to 
interstitial flow mechanosensing that are qualitatively and quantitatively different from 
those in other tissues, and extensive research has been conducted in this area.  We point 
the reader to specific treatments of this topic [164, 188-196].  
 
1.5.1 Blood vessels 
Pressure differences across the vascular wall can result in transmural interstitial 
flow, potentially affecting the behavior of vascular smooth muscle cells and adventitial 
fibroblasts.  Interstitial flow has been shown to play an intimate yet indirect role on smooth 
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muscle cell biochemical signaling and responsiveness [184, 185].  Transmural pressure 
differentials drive interstitial flow velocities of nearly 0.1 – 1.0µm/s [197].  The fluid shear 
stress generated by IFF can be 100 times greater near fenestral pores in the vicinity of 
smooth muscle cells.  This increased shear stress can trigger changes such as increased 
production of prostaglandin I2/E2 by smooth muscle cells in collagen gels [185].  
Physiologically IFF was also shown to initiate signaling crosstalk between the blood vessel 
lumen and smooth muscle cells.  These results demonstrated that IFF and shear stress may 
affect smooth muscle cell proliferation and local vascular tone [185].  Further work 
suggested that interstitial flow can directly govern contraction and relaxation of smooth 
muscle.  It was determined that smooth muscle cells which were exposed to 11 dyn/cm2 
shear stress for 15 minutes exhibited increased contractility via a Ca2+-independent, 
Rho/Rho-kinase-dependent mechanism. This study was one of the first of its kind to reveal 
that interstitial flow shear stresses could affect myogenic responses in smooth muscle cells 
[197].    
In addition to effects on smooth muscle cell function, interstitial flow may also 
affect the motility of vascular cells via the upregulation of MMP-1 [172].  Exposure to an 
approximate interstitial flow velocity of 0.5 µm/s (under a pressure of 1 cm H2O) increased 
migration of myofibroblasts, fibroblasts, and smooth muscle cells [172]. In this 
experiment, cells were initially stimulated by interstitial flow, and then exposed to a 
chemotactic gradient (without flow) to quantify changes in cell motility. Flow-induced 
increases in cell migration were related to increased MMP-1 production and activity in 
response to interstitial flow in smooth muscle cells and fibroblasts [172, 198].  
Furthermore, it was concluded that upregulation of MMPs was dependent on downstream 
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activity of ERK1/2 and transcription factor c-Jun activation [198].  Heparan sulfate 
proteoglycans are components of the glycocalyx that may serve as shear stress sensors 
[199-201].  These glycocalyx heparan sulfate proteoglycans have been shown to mediate 
the mechanotransduction of interstitial flow-induced forces through the FAK-ERK 
pathway in smooth muscle cells [202].   Modulation of smooth muscle cell marker genes 
under interstitial  (1 cmH20, 0.05 dyn/cm
2) was similarly dependent on ERK1/2 activity 
and heparan sulfate proteoglycans, as demonstrated by enzymatic treatment with 
heparinase  [203].  These results, in total, shed light on a possible mechanism of interstitial 
flow mechanotransduction mediated by the heparan sulfate proteoglycans in the 
glycocalyx, integrin and FAK activation, and downstream ERK 1/2 signaling.  These 
findings shed light on the role of interstitial flow-induced fluid shear stress in regulating 
vascular wall cell phenotypes [198, 202, 203].    
 
1.5.2 Lymphatic vessels 
Given the function of lymphatic vessels in interstitial fluid drainage, it should come 
as no surprise that interstitial flow can modulate the behavior of lymphatic endothelial 
cells. Lymphatic drainage and transport of interstitial fluid is important for maintaining 
tissue fluid balance and may also aid in innate and adaptive immunity [156, 204]. Important 
physiological events such as inflammation or tissue injury generate rapid responsive 
measures that include increased vascular permeability, leading to elevated interstitial flow 
and downstream lymphatic drainage. Increased interstitial flow has been shown to 
upregulate intercellular adhesion molecule-1 (ICAM-1) and E-selectin on lymphatic 
endothelial cells, which in turn promoted dendritic cell migration in the presence of flow. 
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There were also associated increases in secretion of the chemokine CCL21 and alterations 
in lymphatic endothelial cell junction proteins such as VE-cadherin. During tissue injury 
or inflammation, the hyperpermeability of blood vessels and concomitant increases in IFF 
can affect lymphatic endothelial cells by increasing chemokine secretion, up-regulating of 
adhesion molecules, and facilitating dendritic cell transmigration [205]. 
IFF also appears to have a significant role in the process of lymphangiogenesis. 
Lymphatic endothelial cells are capable of systematically organizing into working 
lymphatic capillaries, which is crucial for lymphangiogenesis. This study was conducted 
in vivo in mice; a small 2-mm-wide band of skin was removed from the tail and replaced 
with a collagen dermal equivalent and sealed with surgical glue. Fluorescently labeled 
macromolecules were used to trace fluid flow channels and lymphatic capillaries via 
fluorescence microlymphangiography. Using these approaches, it was observed that fluid 
channeling occurred prior to formation a new lymphatic capillary network [182]. In 
addition, cell migration, vascular endothelial growth factor C (VEGF-C) expression, and 
ultimately lymphatic capillary formation appeared driven by primarily in the direction of 
interstitial flow, suggesting that flow was required to dictate the organization of new 
lymphatic vessels. These findings were corroborated by in vitro results that showed that 
IFF had morphological consequences on blood and lymphatic endothelial cells [183]. 
Interstitial flow (10 µm/s flow velocity) stimulated formation of vacuoles associated with 
geodesic actin networks and dendritic extensions in lymphatic endothelial cells, while in 
blood endothelial cells interstitial flow caused enhanced multicellular tubule formation and 
cell alignment. Endothelial cell organization and structure formation was further enhanced 
by interstitial flow when cells were seeded in fibrin gels with fibrin-bound vascular 
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endothelial growth factor (VEGF), suggesting an interstitial flow-induced gradient 
formation mechanism [206]. In addition to understanding how interstitial flow might affect 
lymphangiogenesis and angiogenesis, these findings are important in the broader sense that 
IFF could be utilized to organize endothelial cells into a functional network as part of in 
vitro and in vivo regenerative medicine strategies [183, 206]. 
 
1.5.3 Cancer 
The tumor microenvironment is very different from normal healthy tissue 
structures. Tumor growth causes physical changes to the structure of the 
microenvironment, resulting in matrix stresses, increased matrix stiffness, elevated fluid 
pressure, and alterations to fluid flow [186]. When tumors reach a critical size, they 
promote new blood vessel formation via secretion of VEGF [207]. The permeability of the 
new blood vessels and lymphatic capillaries, along with structural changes to the 
extracellular matrix, generate an increase in interstitial fluid pressure in tumor [208]. 
Tumors can possess an interstitial fluid pressure anywhere between 10 mmHg to 20 mmHg 
higher than normal tissue [170]. At the center of a tumor, the interstitial fluid pressure is at 
its highest, creating at large pressure differential across the tumor edge and driving IFF into 
the surrounding tumor stroma [145, 174, 179]. Thus, interstitial flow may have effects not 
only on the cancer cells themselves, but the various cell types (fibroblasts, endothelial cells, 
immune cells) in the tumor microenvironment. 
Interstitial flow can potentially alter the behavior of tumor cells directly, and a 
seminal study demonstrated that flow and autocrine signaling worked synergistically to 
promote melanoma and breast cancer cell invasion to lymphatics via autologous 
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chemotaxis [209]. The more invasive cell lines expressed high levels of the chemokine 
receptor CCR7, which has been implicated in lymph node metastasis [187], and secreted 
elevated levels of its ligand CCL21. Under IFF (0.2µm/s), this resulted in increased 
invasion and cell polarization in the direction of flow, which could be neutralized by 
function-blocking antibodies for CCR7 and CCL21. This response was further enhanced 
by the presence of downstream lymphatic endothelial cells, which also secrete CCL21, 
suggesting combined effects of autologous and paracrine gradients.   Invasive glioma cells 
showed similar increases in invasion due to an interstitial flow and CXCR4-dependent 
mechanism. Invasive glioma cells under fluid flow were much more invasive due to the 
expression of CXCR4 and autocrine secretion of CXCL12. These in vitro findings were 
linked to interstitial flow patterns in the brain, which themselves have been correlated with 
glioma invasion in vivo [210].  A recent study has further concluded that different 
mechanisms govern fluid flow responsiveness in glioblastoma stem cells in a single patient 
where a subpopulation of these cells respond via CD44-dependent invasion or CXCR4-
CXCL12 autologous chemotaxis [211].  Elevated IFP has been observed to drive IFF in 
solid tumors, recent findings state elevated pressure can alter gene expression associated 
with epithelial-to-mesenchymal transition which promotes collective invasion in MDA-
MB-231 human breast cancer cells [212].  Furthermore, recent findings have indicated 
ERBB2-expressing breast cancer cells exposed to IFF, which have also undergone 
epithelial-to-mesenchymal transition, invade via PI3K activation and require CXCR4 
[213].  These studies demonstrate that IFF plays an active role in tumor cell invasion, 
potentially through the mechanism of autologous chemotaxis. 
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In addition to autologous chemotaxis, there is evidence that interstitial flow may 
drive cancer cell invasion via other mechanisms. In prior work using a microfluidic cell 
culture system, changes in cell migration and morphology were observed in response to 
low velocity IFF [214]. Interestingly, migration both with and against the direction of flow 
was observed, and each seemed to involve different mechanisms. While migration 
downstream was CCR7-dependent, migration upstream was mediated by integrins and 
driven by focal adhesion kinase (FAK) activation [214]. Models incorporating interstitial 
flow and extracellular matrix fiber architecture suggest that FAK activation could be the 
result of fluid drag-induced matrix tension transmitted to integrins [215]. Another 
mechanism for regulating tumor invasion may involve degradation and remodeling of the 
extracellular matrix via MMP activity, as demonstrated in smooth muscle cells and 
fibroblasts [172, 198, 216].  FAK-ERK pathway activation has been shown to upregulate 
MMP expression in response to flow, resulting in enhanced renal carcinoma cell migration 
[217]. However, there is also evidence that interstitial flow can suppress migration of CNS-
1, U87, and U251 glioma cells by downregulating MMP-1 and MMP-2. These results are 
contrary to most findings that interstitial flow promotes cancer cell invasion, but it brings 
to light the potential for a spectrum of tumor cell responses to IFF [218]. 
In healthy tissues, fibroblasts are dynamic contributors to extracellular matrix 
remodeling [219]. In cancer, fibroblasts also drive matrix remodeling and are key 
contributors to tumor progression [220]. Thus, considering the responses of non-tumor 
cells in the microenvironment will also be highly relevant to understanding the role of 
interstitial flow in cancer progression. In previous work, fibroblasts were seeded in 
collagen gels and exposed to IFF in a radial flow chamber, resulting in varying average 
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flow velocities across the chamber (average fluid velocity of 13µm/s near the inlet and 
3.6µm/s at the outlet). Exposure to interstitial flow for 72 hours caused fibroblasts to align 
perpendicular to the flow direction and adopt a more spindle-shaped morphology [142]. 
Changes in cell alignment were matched by changes in matrix alignment as well [142]. 
These morphological changes that resulted from the alignment of fibroblasts and the matrix 
could be a major component in controlling permeability within the microenvironment. In 
addition to cell and matrix alignment, interstitial flow also induced myofibroblast 
differentiation via a transforming growth factor (TGF)–β1-dependent mechanism [221]. 
When IFF rates are elevated, e.g., during inflammation and cancer, fibroblasts may 
differentiate or begin to reorganize the extracellular matrix. The effect of interstitial flow 
on fibroblast-to-myofibroblast differentiation was particularly significant because it 
suggests a role in cancer, which is often characterized by fibrotic stroma and the presence 
of myofibroblasts [220, 221]. 
More recently, studies have examined the potential interactions of tumor cells and 
stromal fibroblasts in the presence of interstitial flow. Experiments with metastatic 
melanoma cells co-cultured with dermal fibroblasts revealed that both tumor cells and 
fibroblasts invaded in response to interstitial flow [216]. Fibroblast invasion was driven 
largely by increased activation of TGF- β1 and  increased degradation of collagen by 
MMPs [216]. Tumor cell invasion, in turn, was facilitated by fibroblast invasion and 
simultaneous “matrix priming” via Rho-dependent fibroblast contractility. This matrix 
priming would lead to local remodeling of the architecture of the cellular 
microenvironment and promote tumor cell invasion. 
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There are many clinical benefits that could be potentially derived from examining 
the role of IFF in cancer progression, given the growing evidence of its effects on tumor 
cell invasion. There is already clinical evidence that elevated interstitial flow velocities at 
the periphery of cervical tumors correlates with increased lymph node metastasis, 
suggesting the potential use of interstitial flow as a diagnostic or prognostic indicator [146]. 
Novel therapeutic agents could prevent or reduce migration of cancer cells by specifically 
targeting pathways stimulated by interstitial flow. More broadly, better understanding the 
context in which a tumor grows and progresses, which necessarily must include the 
contributions of interstitial flow, could lead to advances in a wide array of detection and 
treatment methods for cancer. 
 
1.6 Mechanisms of interstitial fluid flow mechanosensing†  
 
Many studies have shown that biomechanical forces indisputably play a significant 
role within the cellular microenvironment; IFF is one of these forces that can drive 
biochemical and biophysical changes within the cellular microenvironment [142, 145, 181, 
184, 190, 195, 222-226]. The mechanisms by which cells sense and respond to interstitial 
flow remain elusive; currently, there are three major hypothesized mechanisms for 
interstitial flow mechanosensing: shear stress sensing via the glycocalyx, autologous 
gradient formation, and integrin activation due to matrix tension [154, 164, 181, 214, 227-
229]. 
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1.6.1 Glycocalyx shear stress sensing 
Cells subjected to interstitial flow may be stimulated by the shear stresses acting on 
their surface [154]. It is typically assumed that the shear stresses resulting from interstitial 
would be relatively low, especially compared to better understand systems such as blood 
vessels; however, heterogeneous matrix architecture and cell orientation could result in 
localized elevated stresses. One of the ways that cells may sense shear stress is through a 
structure known as the glycocalyx. The glycocalyx is a membrane-bound coating of 
proteoglycans, glycoproteins, hyaluronic acid, and glycolipids [230]. In endothelial cells, 
shear stress can be sensed via the glycocalyx resulting from blood flow. The stress is 
transmitted via core proteins of the glycocalyx, which in turn can initiate signals for 
production of nitric oxide, leading to many downstream affects [229]. These core proteins 
are part of a “bush-like” structure that experiences the drag force at the core protein tips, 
which is amplified on the cortical cytoskeleton due to its length (Figure 3). Prior studies in 
vascular smooth muscle cells suggest that heparan sulfate proteoglycans in the glycocalyx 
(i.e., syndecans and glypicans) are critical to cellular responses to interstitial flow, 
mediated by integrins, focal adhesion kinase (FAK), and extracellular signal-related kinase 
(ERK) [202, 203]. These findings are supported by modeling of interstitial flow and shear 
stress on the glycocalyx, where the solid shear stress transmitted by the glycocalyx can be 
as much as one to two orders of magnitude greater than the predicated fluid shear stress 
applied to the cell [231]. The model also predicts that glycocalyx thickness and 
permeability would strongly affect the solid shear stress, raising the possibility that shear 
stress sensing could be tuned or disrupted by modifying the structure and composition of 
the glycocalyx. These findings suggest that while the fluid shear stresses applied by 
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interstitial flow may be relatively low, the glycocalyx could amplify and transmit those 
stresses to the cell [231]. 
 
 
Figure 3: Glycocalyx-mediated shear stress sensing by a cell exposed to IFF.  
 
 
 
1.6.2 Autologous gradient formation 
Another potential mechanism for interstitial flow sensing revolves around the 
convective mass transport associated with flow. During fluid flow, molecules are 
transported through the tissue interstitium where they are needed; this can cause the 
formation of extracellular gradients, to which cells are exquisitely sensitive [181, 232]. 
Fluid flow can be sensed by solute transport in intervertebral discs; this convective 
transport of molecules provides nutritional needs to the cells allowing them to function 
normally [227].  Similarly, joint loading alters soluble macromolecule distribution in 
articular cartilage via fluid flow. This redistribution of macromolecules alters the 
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regulation of matrix protein formation and degradation of the extracellular matrix of 
cartilage [233]. 
Models of interstitial flow and autocrine morphogen secretion of a single cell 
demonstrate that convective forces alone can establish transcellular autologous gradients 
and bias protein concentrations that can change cellular behavior (Figure 4). These 
gradients can be amplified if the secreted morphogen is matrix binding; these morphogens 
can then be liberated or activated by cell-secreted proteases. Under interstitial flow 
conditions, these proteins released from the extracellular matrix result in amplified 
gradients downstream compared to the soluble form of the same protein [181]. Amplified 
gradients of these morphogens possess capabilities of signaling via receptor tyrosine 
kinases and G-protein coupled receptors [234]. The model demonstrated that biologically 
relevant gradients can result for IFF velocities ranging from 0.12 - 6.0 µm/s, even if the 
Peclet number suggests that diffusion is the dominant mechanism of mass transport. If the 
secreted factor is a chemoattractant, these autologous gradients can drive directed cell 
migration via a mechanism called autologous chemotaxis [209, 235]. While sensing of 
autologous gradients generated by interstitial flow may not fit the traditional definition of 
mechanosensing (which generally involves transmission of stresses or strains), it 
nonetheless represents a mechanism by which cells can transduce the physical phenomenon 
of interstitial flow into an intracellular biochemical signal. 
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Figure 4: Transcellular autologous gradient generated by convective forces (right).  
Under static conditions, no autologous gradient is generated (left). 
 
 
 
1.6.3 Matrix tension and integrin activation 
 
IFF is known to create pressure forces on cells within a three-dimensional 
environment, leading to transcellular stress gradients and asymmetric forces between the 
cell and extracellular matrix [214, 215].  IFF can also create drag forces on matrix fibers 
found on the extracellular matrix [154]. The forces can generate relatively high shear 
stresses on these fibers that can, in turn, be transmitted to engaged integrin receptors 
(Figure 5). This may represent a distinct mechanism from the activation of integrins by 
shear stress transmitted via the glycocalyx, as described above.  Integrins have been shown 
to play important roles in mechanosensing in various systems, such as endothelial cells 
[236] and tumor cells [237]. Cells can sense this fluid drag-induced matrix tension and 
respond via increased integrin and FAK activation [214]. Interestingly, the glycocalyx may 
potentially play a role in this mechanism as well, as models have suggested that integrin 
clustering can be regulated by the glycocalyx [238]. However, compared to glycocalyx 
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shear stress sensing and autologous gradient formation, there is considerably less 
experimental evidence for this hypothetical mechanism. 
 
 
 
 
Figure 5: A cell anchored to the matrix experiences tensile forces stress upstream of 
IFF.  Integrin receptors are able to sense this tension that is transmitted through the 
matrix. 
 
 
 
1.7 Outstanding questions  
 
In the last 20 years, HCC is one of the only three major cancer types observed to 
have increased mortality and possess a steady increase in incidence regardless of the 
current advances in cancer detection and treatment.  The progression of this deadly 
malignancy is often in the background of underlying chronic injury making it difficult to 
detect in early stages.  In recent years, much emphasis has been placed on understanding 
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the process of HCC cell invasion; however, it has become apparent that the progression of 
this disease is not solely dependent on just the cancer cells or biological factors, but also 
their interaction with surrounding cells and tissue [43, 223, 239-242].  A growing body of 
evidence has shown us that cells respond to changes in their microenvironment, resulting 
in altered cellular behavior that can contribute to cancer progression.  However, these 
changes in the TME, specifically biomechanical forces like IFF in particular, are severely 
understudied.  IFF is observed to be elevated within the tumor resulting in increased tumor 
cell invasion [209, 213, 216, 243-247].  The goal of this research is to elucidate the effects 
of IFF on HCC invasion and identify the key molecular components involved.  Uncovering 
the synergistic effect of both matrix stiffness and IFF in the liver TME will establish a 
significant physiological understanding of how mechanical forces and molecular signaling 
pathways alter HCC cell invasion.  
 
 
40 
 
 
CHAPTER 2:  INTERSTITIAL FLUID FLOW INCREASES 
HEPATOCELLULAR CARCINOMA CELL INVASION THROUGH 
CXCR4/CXCL12 AND MEK/ERK SIGNALING
†
 
 
†The content of this chapter was published in the Public Library of Science (PLoS):  Shah, A. D., Bouchard, 
M. J., & Shieh, A. C. (2015). Interstitial Fluid Flow Increases Hepatocellular Carcinoma Cell Invasion 
through CXCR4/CXCL12 and MEK/ERK Signaling. PLoS One, 10(11), e0142337. 
doi:10.1371/journal.pone.0142337 
 
2.1 Introduction 
 
Worldwide, HCC is the second leading cause of cancer-related deaths with over 
746,000 deaths annually [248].  In the United States, it is estimated that there will be 35,560 
new cases of HCC in 2015, making it one of the few types of cancer that is still increasing 
in incidence at a rate of approximately 3% per year [249].  Treatment of HCC remains a 
challenge, with 5 year survival rates for patients with stages IIC and IVA (regional HCC) 
of 10% and for patients with stage IVB (distant HCC) as low as 3% [3].  Chronic hepatitis 
B or C virus infection, non-alcoholic fatty liver disease, alcoholism, obesity, type 2 
diabetes, exposure to alfatoxins, and anabolic steroids may all play a role in the 
development and progression of HCC [250].  The formation of intrahepatic metastases, 
which occurs in 51-75% of HCC tumors, is an indicator of poor prognosis [251].  
Furthermore intrahepatic metastasis can be aggressive as observed in a study of 148 
patients with intrahepatic HCC (stage IVA or III tumors), nearly 86% of the patients 
developed extrahepatic metastases occurring most frequently in the lungs [252]. 
Identification of early stage HCC provides the best opportunities for effectively treating 
this cancer; however, even if detected early, the most successful curative treatment options 
are limited to resection of the diseased liver tissue or liver transplantation [253].  
Unfortunately, studies have shown that HCC redevelops in more than 50% of patients with 
intrahepatic or extrahepatic metastases within the first year [254].  Treatments for late stage 
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or recurring HCC are also limited; palliative treatment options include transarterial 
chemoembolization or pharmaceutical interventions such as Sorafenib, a kinase inhibitor 
which has been shown in a Phase III clinical trial of 602 patients to only improve overall 
survival by 12 weeks. [253, 255].  Poor outcomes have been attributed to the dearth of 
HCC screening in the general population, limited treatment options, and invasiveness of 
the cancer [256].  Therefore, a better understanding of the molecular mechanisms that 
affect HCC development and progression is needed to develop more effective strategies 
for diagnosing and treating HCC.   
In recent years, many studies have emphasized the importance of the tumor 
microenvironment in HCC progression [43].  Factors such as chronic inflammation, liver 
fibrosis, and cellular activity of hepatic stellate cells have been observed to alter the liver 
microenvironment [79].  However, the role of mechanical forces within the HCC tumor 
microenvironment remains poorly understood.  Within the tumor microenvironment, 
changes in biomechanical forces such as solid stress [257], fluid pressure [146], and fluid 
flow [154, 214, 215, 218] have been shown to alter cancer progression [223, 258].  
Interstitial fluid flow (IFF) is one of these altered forces in the tumor microenvironment.    
High permeability of tumor-associated vasculature has been shown to alter fluid 
movement, likely due to changes in hydrostatic and oncotic pressure [223].  Previous 
studies identified that most solid tumors have increased interstitial fluid pressure [150].  
Interstitial fluid pressure in a healthy liver was found to be -2.2 mmHg, while the interstitial 
fluid pressure in a hepatoma ranged between 0-30 mmHg [259].  The resulting increase in 
tumor interstitial fluid pressure leads to a steep pressure gradient between the tumor and 
stroma that drives elevated IFF [144, 223].  Computational models have predicted IFF 
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velocities between 0.1 – 6.0 μm/s under various conditions [181].  IFF velocity in mice 
with VEGF165-expressing tumors was measured to be 0.1 - 0.5 μm/s, and even greater 
velocities (1.0 – 8.0 µm/s) were observed in mice with human cervical carcinoma and 
melanoma xenografts [145, 146].  In vivo IFF velocities in cervical cancer patients with 
pelvic lymph node metastases were measured to be between 10 – 55 μm/s [146].  IFF has 
been shown to affect various cellular processes such as differentiation [244], 
morphogenesis [183, 214], and protein secretion [144, 235].  In cancer, IFF can promote 
cancer cell invasion [209, 245], alter stromal fibroblast behavior [216],  and increase MMP 
secretion [218].  Previous studies have revealed that cells can sense interstitial flow through 
glycocalyx-mediated shear-stress sensing [229], autologous-gradient formation [181], and 
integrin activation due to fluid-drag forces and cell-matrix adhesion [214].  In a mechanism 
referred to as ‘autologous chemotaxis’, IFF combines with autocrine chemoattractant 
secretion to form an autologous gradient that directs tumor-cell migration [181, 209, 216, 
235, 244, 247].  Computational models have shown that slow-moving fluid, in combination 
with cell-secreted proteins, can generate a pericellular chemoattractant gradient that is 
sufficient to trigger a physiological response such as chemotaxis [181, 209].  Previous 
studies have also shown that human breast cancer cell lines exhibit increased invasion in 
the direction of IFF via a CCR7-dependent mechanism, while glioma cell invasion can 
occur through CXCR4-dependent autologous chemotaxis [209, 235].  In HCC, studies have 
shown that CXCR4 and CXCL12 play a pivotal role in extrahepatic metastasis [260], 
migration [261, 262], and patient prognosis [263]. To date, however, no studies have 
examined the role of interstitial flow and autologous chemotaxis (potentially via 
CXCR4/CXCL12) in HCC cell invasion.  
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The increase in IFF in tumors results in increased tumor cell invasion in various 
cancer types; however, to date there is no study that has investigated the effects of IFF in 
HCC [213, 216, 235, 247].  We hypothesized that increased IFF induces greater HCC 
invasion in a velocity-dependent fashion.  IFF velocity in various solid tumors has been 
observed to be significantly higher than flow rates found in normal tissue [145].  
Consequently, peritumoral IFF velocity has been observed to be an indicator of low 
survival in human cervical carcinoma patients [146].  Understanding and profiling IFF 
velocity on HCC cell invasion could serve as a potential prognostic indicator for HCC 
progression and patient survival.  Furthermore, we hypothesized that HCC cells invade in 
response to IFF through the autologous formation of a CXCL12 chemokine gradient.  In 
the studies described here, we have analyzed the effects of IFF on HCC cell invasion and 
have identified a key molecular pathway that is involved in liver cancer cell invasion.  We 
show that IFF-induced HCC invasion is dependent on an autologous chemotaxis via 
CXCR4 and CXCL12, as well as MEK/ERK activation. The results of our studies suggest 
a potential role for IFF in the invasive potential of HCC.   
 
2.2 Methods 
 
Cell Isolation and Culture 
Hepatoma-derived Huh7 and Hep3B cells were cultured in Roswell Park Memorial 
Institute (RPMI) 1640 with L-glutamine (Cellgro, Manassas, VA) supplemented with 10% 
fetal bovine serum (FBS) and 1% penicillin/streptomycin.  HepG2 hepatoblastoma-derived 
cells were cultured in Minimal Essential Medium (MEM) (Cellgro) supplemented with 
10% FBS, 1% non-essential amino acids (NEAA), 1% sodium pyruvate, and 1% 
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penicillin/streptomycin on collagen-coated cell-culture plates. Rat hepatocytes (PRHs) 
were isolated from 5-7 week old male Sprague-Dawley rats using a 2-step perfusion 
method [264].  Surgery and isolation of rat hepatocytes were approved by the Institutional 
Animal Care and Use Committee of Drexel University College of Medicine and complied 
with the Animal Welfare Act, the Public Health Service Policy of Humane Care and Use 
of Laboratory Animals, and the National Institutes of Health (United States) Guide for the 
Care and Use of Laboratory Animals [265, 266]. PRHs were used within 3 hours of 
isolation to prevent hepatocyte de-differentiation.  The PRHs were maintained in Williams 
E medium (Life Technologies, Carlsbad, CA) supplemented with 2 mM L-glutamine, 1 
mM sodium pyruvate, 4 µg/ml insulin/transferrin/selenium (ITS), 5 µg/ml hydrocortisone, 
5 ng/ml epidermal growth factor (EGF), 10 µg/ml gentamycin, and 2% dimethyl sulfoxide 
(DMSO).  All cells were maintained in a humidified 37˚C environment with 5% CO2.   
 
3D Interstitial Flow Invasion Assay  
The liver cells (5.0 x 105 cells/ml gel) were encapsulated in a gel comprised of 1.3 
mg/ml rat tail tendon type I collagen (BD Biosciences, San Jose, CA) and 1 mg/ml Matrigel 
(BD Biosciences) and seeded into 12 mm diameter, 8 µm pore diameter culture inserts 
(Millipore, Bellerica, MA).  Static and flow conditions were generated over the course of 
24 hours by following a previously described method [209, 216, 267].  For the static 
condition, the level of basal medium outside of the transwell was level with the medium 
inside the transwell, resulting in little to no hydrostatic pressure difference.  The IFF 
condition was created by adding more basal medium to the inside of that transwell than the 
outside, resulting in a hydrostatic pressure difference of approximately 1 mm Hg.  This 
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drove IFF through the collagen gel, with an average velocity of approximately 0.05 – 0.1 
µm/s (based on average volumetric flow rate and the cross-sectional area of the gel).  This 
velocity is on the lower end of velocities measured in or modeled for tumors, but much 
higher than the IFF velocities predicted for normal hepatic lobules [145, 146, 268].  Cells 
that transmigrated through the porous membrane were fixed with 4% paraformaldehyde 
(Sigma-Aldrich, St. Louis, MO) and stained with DAPI (2 µg/ml, MP Biomedicals, Santa 
Ana, CA).  Fixed and stained cells were imaged by fluorescence microscopy.  Both static 
and flow conditions were analyzed by counting five locations on the fixed membranes.  
Percent invasion was calculated with the following equation: 
 
% -.#/01. = 2	345#64 7488 71).9 ∗ 	;4<=5#.4 /)5>#74 #54#	-<#64 #54# ∗ 	?)<=45 1> 7488/ /44@4@ A ∗ 100 
 
 
Figure 6:  Schematic of the 3D invasion assay.  The collagen/Matrigel matrix (pink) 
is seeded with HCC cells (green).  Interstitial flow is simulated with basal media (blue) 
and the fluid flow is drive by the pressure head generated by the basal media. 
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For specific experiments, pharmacological inhibitors, neutralizing antibodies, or 
recombinant proteins were added to the cell/gel mixture before gel polymerization and in 
the media used for the experiment at their respective target concentrations (Table 1). 
 
 
Table 1: List of pharmacological inhibitors and neutralizing antibodies. 
 
Agent Source Target Concentration 
AMD3100 R&D Systems CXCR4 12.6 µM 
CXCL12 neutralizing antibody R&D Systems CXCL12 3 µg/ml 
U0126 Selleckchem MEK1/2 25 µM 
FR180204 Tocris ERK1/2 10 µM 
 
 
 
Measurement and calculation of IFF velocity 
 
 To determine IFF velocity, the normal 3D invasion assay with Huh7 cells was set 
up as described previously was utilized with varying velocity conditions:  static, low flow, 
medium flow, medium-high flow, and high flow conditions.  To achieve a broader range 
of flow velocities, we increased the permeability of the collagen matrix by removing 
Matrigel, and confirming that IFF still induces invasion in the absence of Matrigel and all 
the factors it contains.  IFF velocity was determined by collecting the basal medium that 
flowed through the Boyden chamber and measuring its volume.  Every hour the basal 
medium was collected and replenished to the respective volume for low flow – 162.5 µl, 
medium flow – 325 µl, medium-high flow – 487.5 µl, and high flow – 650 µl.  This was 
repeated for 6 hours and finally the cells were fixed, stained, and imaged for quantification 
of flow-induced HCC invasion.  It is important to note that normal invasion experiments 
were conducted for 24 hours without refill of Boyden chambers.  The volume of basal 
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medium collected each hour was measured and recorded.  This value was utilized to 
determine fluid flow velocity as described in the following equation:    
C =  ∗ 3 
Q: volumetric flow rate; v: mean velocity; A: cross-sectional area of flow: 3 = 1.131 ∗ 10EF< 
 
 
Western Blot 
Western blot was used to measure changes in total and phosphorylated protein 
levels in response to IFF and specific inhibitors.  Cells were lysed with 
radioimmunoprecipitation assay (RIPA) buffer containing Halt protease and phosphatase 
inhibitor cocktail (Thermo Scientific, Waltham, MA).  For 3D samples, cells were first 
digested out of the gels with collagenase D (0.5625 U/ml, Roche Life Science, 
Indianapolis, IN) for 45 minutes and then centrifuged for 10 minutes at 1,000 RPM.  The 
following primary antibodies were used to detect the proteins of interest:  anti-CXCR4 
(1:1,000, Abcam, Cambridge, England), MEK1/2 (1:1,000, Cell Signaling Technology, 
Beverly, MA), phospho-MEK1/2 (Ser217/221) (1:1,000, Cell Signaling Technology, 
Beverly, MA), ERK1/2 (1:1,000, Cell Signaling Technology, Beverly, MA), phospho-
ERK1/2 (Thr202/Tyr204) (1:1,000, Cell Signaling Technology, Beverly, MA), and β-actin 
(13E5) (1:2,000, Cell Signaling Technology, Beverly, MA).  The following secondary 
antibodies were used: rabbit anti-mouse IgG-HRP (1:10,000, Abcam, Cambridge, 
England), goat anti-rabbit IgG-HRP (1:10,000, Abcam, Cambridge, England), and anti-
rabbit IgG (1:2,000, Cell Signaling Technology, Beverly, MA).  Chemiluminescence 
imaging was conducted with a FluorChem M imaging system (Proteinsimple, San Jose, 
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California) and quantified with AlphaView (Proteinsimple, San Jose, California).  Target 
protein levels were normalized to β-actin. 
 
CXCL12 Chemotaxis Assay 
Huh7 cells (1.25 x 105 cells/ml gel) were added to the same type of gel and cell-
culture inserts used for the 3D flow invasion assay.  Cells were exposed to a gradient of 
recombinant human CXCL12 in a checkerboard method, by adding a known concentration 
of CXCL12 (10 nM) in the medium only above, below, or above and below the gel (or a 
control condition with no CXCL12) for 24 hours at 37˚C with 5% CO2.  Cells that migrated 
through the membrane of the cell-culture insert were fixed and stained.  Invasion was 
quantified following the same method described for the 3D flow invasion assay.  
 
Enzyme-linked immunosorbent assay (ELISA) 
Protein from 2D cell lysates and medium were collected from approximately 8.0-
11 x 106 HCC cells after 4 days of incubation at 37˚C and 5% CO2 in a T75 flask with full 
media.  Protein from 3D cell lysates and medium were collected from 5.0 x 105  liver cells 
after 1 day of incubation at 37˚C and 5% CO2 in a collagen/Matrigel matrix.  Protease 
inhibitors were added to all cell lysates and media.  CXCL12 levels were quantified using 
a commercially available DuoSet ELISA kit (R&D Systems, Minneapolis, MN).  Standard 
curves were generated using known concentrations of recombinant human CXCL12 and 
data were fit with a four parameter logistic curve in MATLAB (MathWorks, Natick, MA).   
 
 
49 
 
 
Statistical Analysis 
All data are presented as mean ± standard error of the mean (SEM).  All results for 
invasion assays are based on a minimum of two independent experiments with sample size 
n ≥ 3 for each experiment.  Statistical significance between two groups was determined by 
conducting a Student’s t-test.  For three or more groups, one or two-factor AVOVA with a 
Bonferroni or Tukey’s multiple comparison test was utilized.  GraphPad Prism 5 (San 
Diego, CA) was used to perform statistical analyses.   
 
 
2.3 Results 
 
IFF enhances HCC cell invasion  
 
A panel of human liver-derived cell lines consisting of Huh7 (human hepatoma 
cells), HepG2 (human hepatoblastoma cells), and Hep3B (human hepatoma cells with 
integrated hepatitis B virus genome), along with PRHs, were exposed to IFF in the 3D flow 
invasion assay to quantify the effects of IFF on cell invasion.  Huh7, Hep3B, and HepG2 
cells exposed to IFF showed increased invasion in comparison to cells in static (no IFF) 
conditions (Figure 7A).  Notably, the percent invasion of Huh7 cells exposed to IFF was 
much higher than Hep3B, HepG2, and PRHs (Figure 7A).  When data were normalized to 
their respective static controls, the hepatoma-derived Huh7 and Hep3B cells showed the 
most dramatic response to interstitial flow, with nearly a 5.5 fold increase in invasion due 
to IFF (Figure 7B).  In contrast, HepG2 cells showed only a 2.1 fold increase in cellular 
invasion in response to IFF (Figure 7B).  PRHs exposed to IFF did not show any significant 
changes in invasion.   
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Figure 7: Interstitial flow induces invasion of HCC cell lines.  (A) Percentage of HCC 
and PRHs that have invaded in response to fluid flow.  Huh7, n=23 (static and flow); 
Hep3B, n=15/21 (static/flow); HepG2, n=21/19 (static/flow); PRH, n=9 (static and flow).  
*, p < 0.05.  (B) Invasion results (identical to A) presented as normalized to each cell type’s 
respective static condition.   
 
 
Flow-induced HCC cell invasion is velocity-dependent 
 In order to vary the fluid flow velocity, two major parameters were changed to 
simulate physiologically relevant fluid flow velocities.  First, Matrigel was removed from 
the matrix and the Huh7 cells were encapsulated solely in type I collagen (Samples B-E, 
Figure 8A), resulting in decreased matrix permeability allowing increased basal medium 
to flow through.  Next, altering the hydrostatic pressure within the Boyden chamber by 
adjusting the volume of basal medium placed inside would result in changes to the fluid 
flow rate, ultimately varying the velocity.  Four different velocities along with a static 
control was utilized to observe the effects of the varying flow velocities of basal medium 
on the invasiveness of the encapsulated cells.   Our results indicate that there is a correlative 
relationship between fluid flow velocity and Huh7 cell invasion (Figure 8A).  Additionally 
it is apparent that the overall invasion percentage is much lower than the invasion results 
observed in (Figure 8A).  It is important to keep in mind that the set of experiments 
examining velocity were only conducted for a 6 hour period with constant fluid flow, while 
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the traditional 3D invasion assay required 24 hours with decreasing fluid flow velocity.  
Additionally linear regression analysis established a positive relationship with fluid flow 
velocity and Huh7 cell invasion (Figure 8B, R2 = 0.2763).     
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Figure 8: Flow-induced HCC invasion is velocity-dependent.  (A) Huh7 cells exposed 
to varying fluid flow velocities for 6 hours.  Matrix conditions A, B, C, D, and E = collagen 
only.  Flow type dictated by volume of basal medium placed inside transwell every 
hour.   ̵̵̵  ̵̵̵  ̵̵̵  = collagen + matrigel static condition and   ̶̶   ̶   ̶  = collagen + matrigel flow 
condition.  * = p < 0.05 between static vs. flow condition.  n.s. = not significant between 
low flow and static collagen only condition. (B) Linear regression analysis results in 
positive relationship between fluid flow velocity and Huh7 cell invasion. (R2 = 0.2763.  
Slope significantly differs from zero, p = 0.0012).   
 
 
 
IFF-induced HCC invasion depends on CXCR4 
The chemokine receptor CXCR4 has been shown to mediate cellular functions such 
as proliferation, migration, invasion, and adhesion in a variety of cancer types [235, 260, 
269].  Studies have shown that HCC cells possess higher CXCR4 and CXCL12 protein 
levels in HCC metastases compared to normal hepatic tissues [260, 261].  This evidence 
further suggested CXCR4/CXCL12 could potentially promote tumor cell migration.  
Additionally, IFF has been shown to enhance glioma invasion through CXCR4/CXCL12-
dependent autologous chemotaxis [235].  Thus we hypothesized that IFF-induced HCC 
cell invasion depends on the CXCR4/CXCL12 chemokine axis.  To block CXCR4 activity, 
we incorporated the CXCR4 antagonist AMD3100 (12.6 µM) into the 3D invasion assay.   
AMD3100 significantly decreased IFF-induced invasion of both Huh7 and Hep3B cells, 
but had no statistical effect on HepG2 cells and PRHs (Figure 9A).  To determine if the 
differences in IFF-induced invasion between Huh7, Hep3B, and HepG2 cells, and their 
sensitivity to AMD3100, was due to CXCR4 expression, we performed western blot 
analyses to measure CXCR4 levels.  We confirmed the presence of CXCR4 in both 2D and 
3D cultures of all three cell lines (Figure 9B).  A quantitative analysis of CXCR4 levels 
showed that CXCR4 expression did not vary significantly between the cell lines, and IFF 
had no effect on CXCR4 levels in 3D conditions (Figure 9C).  Overall, these findings 
54 
 
 
suggest that CXCR4 is necessary but not solely responsible for IFF invasion.  Moreover, 
IFF does not modulate levels of CXCR4, nor does responsiveness to IFF correlate with 
CXCR4 protein expression in the cell lines tested.  
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Figure 9 : Interstitial flow-induced HCC invasion depends on CXCR4.  (A)  CXCR4 
antagonist AMD3100 (12.6 µM) inhibits IFF-induced invasion.  Huh7 (n=18), Hep3B 
(n=18), HepG2 (n=12), and PRH (n=6). * = p < 0.05 between each respective cell line and 
its corresponding treatment condition.  # = p < 0.05 between static vs. flow conditions.  
(B) CXCR4 is detected in HCC cell lines in both 2D and 3D lysates.  CXCR4 = 43 kDa.  
Static 3D sample, (-) and Flow 3D Sample, (+).  (C) Quantitative western blot analysis of 
CXCR4 compared to its respective control, β-actin.  Percentage adjusted relative density 
compared to loading control of respective sample.  Static 3D sample, (white bar); Flow 3D 
Sample, (black bar).   
 
 
IFF-induced Huh7 invasion requires an autologous CXCL12 gradient 
Given the functional role of CXCR4 (Figure 9), we next investigated the 
involvement of CXCL12 in IFF-induced invasion of Huh7 cells.  The Huh7 cells showed 
the strongest invasion response to IFF; therefore, we proceeded with primarily this cell line 
in subsequent experiments.   Incorporating a CXCL12 neutralizing antibody in the 3D 
invasion assay resulted in a significant reduction in IFF-induced Huh7 invasion (Figure 
10A), suggesting that CXCL12 is necessary for IFF-induced invasion.  Based on the 
functional response of the Huh7 cells in our serum-free invasion assay conditions, it 
appeared that these cells are secreting CXCL12.  One of the key features of the hypothetical 
autologous chemotaxis mechanism is a pericellular chemoattractant gradient caused by 
IFF.  To diminish the relative magnitude of any cell- and IFF-generated CXCL12 gradient, 
we added a uniform 10 nM concentration of recombinant CXCL12 to the 3D invasion 
assay.  This resulted in decreased IFF-induced invasion compared to the untreated 
condition (Figure 10B).  This suggests that a CXCL12 gradient is necessary for IFF-
induced invasion, consistent with the previously hypothesized autologous chemotaxis 
mechanism [235].  We also confirmed that Huh7 cells chemotact in response to CXCL12 
through a 3D chemotaxis assay (Figure 10C).  Finally, to determine if CXCL12 secretion 
levels vary between the Huh7, Hep3B, and HepG2 cells, which could potentially explain 
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the differential responses to IFF,  intracellular and secreted CXCL12 in 2D and 3D (static) 
environments was quantified by ELISA (Figure 10D).  In the 2D conditions, the Hep3B 
cells secreted the greatest amount of CXCL12 in the medium, while HepG2 secreted no 
detectable amounts.  The lysates of the 2D conditions exhibited low amounts of CXCL12 
(~2 pg CXCL12/106 cells) for all three cell lines.  Between the three cell lines in 3D 
conditions, all three cell lines showed relatively similar levels of CXCL12 in lysate and 
medium.  While greater amounts of CXCL12 were measured in the lysates of the cells in 
the 3D condition compared to the 2D condition, there was no clear correlation between 
IFF-induced invasion and levels of CXCL12 secretion.   
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Figure 10: Detection of CXCL12 and its functional role in HCC.  (A) Huh7 cells treated 
with CXCL12 neutralizing antibody and respective control (3 µg/ml) for 24 hours in a 3D 
invasion assay (n=9).  * = p < 0.05 between each respective treatment condition.  # = p < 
0.05 between static vs. flow conditions of the two treatment.    (B) Invasion assay (n=12) 
on Huh7 cells with/without CXCL12 (80 ng/ml) conditioned medium was conducted to 
observe changes in flow-induced cellular invasion.  Test condition: + = exogenous 
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CXCL12 added to media; - no exogenous CXCL12 present in media.  Significance between 
static vs. flow, * = p < 0.05.  # = p < 0.05 between static vs. flow conditions of the two 
treatment options.  (C)  Chemotaxis assay conducted on Huh7 cells in static environment 
(n=18).  Exogenous CXCL12 – 80ng/ml.  Test condition: + = exogenous CXCL12 added; 
- = no exogenous CXCL12 present.  **** = p < 0.0001.  (D) Average CXCL12 expression 
in 2D and 3D lysates (static) and respective medium was measured with ELISA.  Sample 
type: cell line (n=lysate/n=medium) – 2D: Huh7 (n=7/n=6), Hep3B (n=3), HepG2 (n=3).  
3D: Huh7 (n=6), Hep3B (n=6/n=5), HepG2 (n=5/n=6). 
 
 
 
MEK/ERK signaling is required for IFF-induced HCC cell invasion 
Our previous results demonstrate that the CXCR4/CXCL12 signaling axis plays a 
critical role in IFF-induced HCC invasion, but utilization of a CXCR4 antagonist and the 
CXCL12 neutralizing antibody does not eliminate this flow-induced invasion entirely 
(Figure 9 and Figure 10).  Rather these results suggest that IFF-induced invasion of HCC 
cells is not regulated solely by CXCR4/CXCL12 chemokine signaling, but may involve 
other molecular mediators.  Previous studies have observed elevated levels of MEK and 
ERK in HCC, which have been shown to contribute to HCC cell proliferation, 
differentiation, tumor progression, alter cell cycle regulation and apoptosis [26, 270, 271]. 
Given that increased MEK1/2 and ERK1/2 activity has been observed in HCC, we 
investigated whether these kinases affect IFF-induced HCC invasion [26, 270].  Huh7 cells 
in the 3D invasion assay were treated with the MEK1/2 inhibitor U0126 (25 μM), which 
resulted in a significant decrease in IFF-induced invasion compared to the vehicle (DMSO) 
control (Figure 11A).  Similarly, inhibition of ERK1/2 activity by FR180204 (10 µM) 
resulted in significantly decreased IFF-induced invasion of Huh7 cells (Figure 11B).  The 
inhibitor concentrations used in these experiments were confirmed to be non-cytotoxic in 
3D culture conditions.  A western blot was conducted on protein from Huh7 3D samples 
and showed no change in total MEK1/2 levels between the static control and IFF condition 
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(Figure 11C).  Exposure to IFF and/or AMD3100 had no effect on phosphorylated MEK1/2 
(pMEK1/2) or ERK1/2 (pERK1/2) levels in Huh7 cells (Figure 11C). This lack of change 
in pMEK1/2 and pERK1/2 levels with IFF or AMD3100 exposure suggests that IFF is not 
activating MEK or ERK via CXCR4 signaling.  We also verified that U0126 inhibits 
MEK1/2 activity by observing the loss of pERK1/2 with U0126 treatment (Figure 11C).  
Levels of pMEK1/2 were similar between Huh7, Hep3B, and HepG2 cells, and IFF did not 
show any effect on these levels compared to their respective static conditions (Figure 11D).  
Furthermore CXCR4 levels were measured from the lysates of Huh7 cells seeded in a 
collagen gel with U0126 (25 μM) and FR180204 (10 μM) inhibitor treatments, and DMSO 
vehicle control (Figure 11E).  No change in CXCR4 levels in the Huh7 cell was observed 
with MEK1/2 or ERK1/2 inhibition.  Similarly, there were no significant changes in 
secreted or intracellular CXCL12 in Huh7 cells treated with the MEK1/2 or ERK1/2 
inhibitors (Figure 11F).  These findings suggest that MEK/ERK signaling is involved in 
IFF-induced invasion, but is not upstream or downstream of CXCR4 and CXCL12.  
Instead, MEK/ERK may be modulating other pathways necessary for IFF-induced 
invasion.   
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Figure 11: MEK/ERK required for flow-induced HCC cell invasion.  (A) MEK1/2 
inhibitor (U0126) at 25 µM incorporated in the 3D invasion assay with Huh7 cells (n=14).  
Significance between static vs. flow, * = p < 0.05.  # = p < 0.05 between static vs. flow 
conditions of the two treatment options assessed by a two-way ANOVA.    (B) ERK1/2 
inhibitor (FR180204) at 10 µM incorporated in the 3D invasion assay with Huh7 cells 
(n=9).  Significance between static vs. flow, * = p < 0.05.  # = p < 0.05 between static vs. 
flow conditions of the two treatment options assessed by a two-way ANOVA.  (C)   
Western blot conducted to detect the presence of total MEK1/2 protein collected from 
Huh7 cells under static and flow.  pMEK1/2 was detected in Huh7 cells that were 
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incorporated in the 3D invasion assay and exposed to AMD3100.  MEK1/2 and pMEK1/2 
= 45kDa.  pERK1/2 was detected in Huh7 cells that were incorporated in the 3D invasion 
assay and exposed to treatments of U0126 or AMD3100.  pERK1/2 = 42/44kDa.  (D) 
pMEK was detected in Huh7, Hep3B, and HepG2 cells.  (E) Western blot conducted to 
detect total CXCR4 protein collected from Huh7 cells in 3D collagen gels treated with 
U0126, FR180204, and DMSO (vehicle control).  (F) Average CXCL12 expression 
measured from protein of Huh7 cells seeded in 3D collage gel and treated with U0126, 
FR180204, and DMSO (vehicle control). 
 
 
 
2.4 Discussion 
 
IFF is slow moving fluid flow that occurs in normal tissues; however, in tumors 
this fluid flow is elevated, potentially driving increased cell invasion [214, 216, 235, 244, 
247].  In this study we characterized the effects of IFF determined this response to fluid 
flow was velocity-dependent, and there was a positive relationship between IFF velocity 
and Huh7 cell invasion (Figure 8).  Furthermore, our findings indicate that our static 
condition has similar invasion percentage to a low flow condition, suggesting a static 
condition is not very different from low physiological IFF from an invasion standpoint.   
Tumor interstitial pressure has been shown to create steep pressure gradient between the 
tumor and stroma that drives elevated IFF [144, 223].  Tumor pressure in the liver has been 
observed to be a reliable prognostic factor and useful tool for local recurrence for patients 
with tumors that were 3 cm or smaller in size [272].  Computational models have predicted 
IFF velocities between 0.1 – 6.0 μm/s under various conditions [181].  IFF velocity in mice 
with VEGF165-expressing tumors was measured to be 0.1 - 0.5 μm/s, and even greater 
velocities (1.0 – 8.0 µm/s) were observed in mice with human cervical carcinoma and 
melanoma xenografts [145, 146].  In vivo IFF velocities in cervical cancer patients with 
pelvic lymph node metastases were measured to be between 10 – 55 μm/s [146].  The fluid 
velocity observed in our system was on the lower end compared to some previous in vivo 
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findings mentioned previously, however the corresponding invasion results in the short 6 
hour period in our system were significantly increased.  The standard invasion assay with 
Huh7 cells in a collagen and Matrigel matrix for 24 hours resulted in a higher overall 
average invasion than the Huh7 cells in the 6 hour collagen only matrix invasion assay with 
high fluid flow.  This elevated velocity could increase cell invasion in a variety of ways, 
cell-secreted proteins are capable of forming gradients at interstitial flow velocities as high 
as 6.0 μm/s with low physiological Peclet numbers (Pe < 1.0).  Previous work has shown 
that these gradients form in a bias manner as velocity increases or the diffusion coefficient 
of the secreted protein decreases.  The formation of such gradient can provide chemotactic 
ques for the cells resulting in increased migration or invasion in the direction of these 
gradients [181].  One of the caveats in our study is that the effects of elevated IFF in our 
3D invasion assay with only collagen could alter cellular adhesion properties in the Huh7 
cells.  The standard 3D invasion assay contains cells encapsulated in a collage and Matrigel 
matrix to simulate the TME.  However due to the limitations in our fluid flow assay, 
controlling the flow velocity required the removal of Matrigel.  A significant range of IFF 
velocities have been observed in many models and in general higher IFF velocities have 
been related to poor outcomes for cancer patients.  The liver is an extremely vascular tissue 
structure, and examining the effects of IFF on HCC cells could result in novel therapies to 
treat and detect HCC.  Understanding and characterizing the effects of fluid flow on HCC 
cells will allow us to better understand various stages of HCC and how this cancer type 
progresses.   
To date, several studies have demonstrated that IFF can drive glioma, melanoma, 
renal, and breast cancer cell invasion [209, 213, 214, 216, 235, 247] via one of three 
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proposed mechanisms: IFF-induced tension transduced by cell-matrix adhesions, 
glycocalyx-mediated shear stress sensing and downstream upregulation of MMP, and 
autologous chemotaxis.  In this study, we demonstrate for the first time that IFF can induce 
invasion of HCC cells through the formation of autologous transcellular gradients of 
CXCL12.  Furthermore, IFF-induced invasion of Huh7 cells requires MEK/ERK activity 
independent of CXCR4/CXCL12 signaling.  High expression of CXCR4 and CXCL12 has 
been observed in various carcinomas, resulting in increased cell migration and tumor 
angiogenesis [269, 273].  In HCC, CXCR4 and CXCL12 have been associated with 
variations in the cell cycle resulting in increased risk of metastasis formation in bone, and 
elevated levels of the chemokine enhances migration of the tumor cells [260, 262, 263].  
We showed that HCC flow-induced invasion occurs through a CXCR4-dependent 
mechanism (Figure 9).  Tumor dissemination and poor HCC prognosis have been linked 
to the expression of this chemokine receptor [261].  This CXCR4-dependent mechanism is 
not complete without the secretion of its ligand CXCL12.  CXCL12, also known as stromal 
cell-derived factor 1 (SDF-1), has been shown to mediate important cellular processes such 
as chemotaxis and leukocyte trafficking [274].  We observed that CXCR4 and CXCL12 
are necessary for IFF-induced invasion and that the levels of the chemokines did not change 
when exposed to IFF (Figure 10).  The presence of CXCR4 and CXCL12 was necessary 
for IFF-induced invasion in HCC cells.  A potential reason as to why non-HCC cells such 
as the PRHs did not respond to flow-induced invasion could be due to the lack or low levels 
of either the CXCR4 receptor or its ligand CXCL12.  Previous work identified CXCR4 
messenger RNA (mRNA) and protein levels in HCC tissues and cell lines, but could not 
detect CXCR4 in normal hepatic tissues.  Similarly, CXCL12 was detectable in HCC 
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patients’ ascites fluid but not in normal hepatic tissue [260].  No further experiments were 
conducted with PRHs because they did not respond to IFF; instead, we focused our efforts 
to uncover the molecular mechanisms of IFF-induced HCC cell invasion.  Ultimately, we 
were unable to identify any relationship between total protein levels of CXCR4 or CXCL12 
and response to IFF; however it is important to note that autologous chemotaxis does not 
require increased expression of the receptor or secretion of the ligand, but requires the 
formation of a gradient [181].  Furthermore we observed differences in IFF-induced 
invasion between the three liver cancer cell lines in our study.  It has been observed that 
Huh7 and Hep3B cells, exposed to CXCL12, respond with rapid perinuclear translocation 
of CXCR4 while HepG2 cells do not due to a receptor defect [261, 275].  Moreover, it was 
also previously shown that Huh7 cells showed a strong invasive response once exposed to 
CXCL12, which is quite similar to our findings (Figure 10) [261].  In conclusion, we 
identified the CXCR4/CXCL12 signaling axis to be a significant component in IFF-
induced invasion in HCC; however, this signaling was not the only mechanism involved 
in IFF-induced invasion of HCC cells, as shown by the presence of some IFF-induced 
invasion even with inhibition of CXCR4 or CXCL12 (Figure 9A and Figure 10B).   
In the past twenty years, much emphasis has been placed on the Raf-MEK-ERK 
signaling cascade to better understand its potential therapeutic benefits for cancer therapy.  
The MEK/ERK signaling cascade has been observed to be highly active in HCC and shown 
to regulate invasion and formation of metastasis in HCC cells [26].  Recent studies 
investigating the molecular pathogenesis of HCC have revealed that blocking MEK/ERK 
signaling in HCC cells results in multiple anticancer effects such as decreased HCC cell 
proliferation, growth, and increased apoptosis [271].  In HCC tissue specimens, MEK/ERK 
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signaling has been shown to be constitutively activated in many specimens, and inhibition 
of the MEK/ERK pathway in our study resulted in a significant decrease of IFF-induced 
invasion (Figure 11A and Figure 11B) [26].  Some studies have also suggested crosstalk 
between CXCR4/CXCL12 activation and MEK/ERK signaling that influences cellular 
invasion [27].  One study demonstrated that CXCR4/CXCL12 signaling resulted in 
increased phosphorylation of ERK in Huh7 cells [276].  In contrast, we demonstrated that 
CXCR4/CXCL12 signaling did not alter the MEK/ERK pathway in our liver cell lines 
(Figure 11C).  This could be a result of the differences in the experimental model; our 
studies are performed in 3D, while the previous study used cells cultured in 2D.  
Furthermore, we determined that MEK/ERK signaling and chemokine signaling 
independently altered HCC cell invasion (Figure 11E and Figure 11F).  Thus, we 
hypothesize that IFF-induced invasion of HCC cells depends on several different 
mechanisms.  For example, the MEK/ERK signaling cascade has been implicated in the 
enhanced secretion of MMPs in HCC resulting in increased cell migration and invasiveness 
[277, 278].  However further investigation would be required to elucidate the role of 
MEK/ERK signaling in IFF-induced invasion.   
In this study, we elucidated CXCR4/CXCL12-dependent autologous chemotaxis as 
a significant mechanism involved in IFF-induced invasion of HCC cells.  Additionally we 
identified MEK/ERK signaling as a significant contributor to IFF-induced invasion, but 
one that is independent of the CXCR4/CXCL12-autologous chemotaxis mechanism.  
However as previously mentioned, mechanisms of IFF mechanosensing are not fully 
understood.  The formation of autologous transcellular gradients is merely one potential 
mechanism that cells may use to sense and respond to IFF.  Another possible mechanism 
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involves glycocalyx shear stress sensing, where flow-induced stresses are transduced into 
and transmitted as solid stresses through core proteins of the glycocalyx, leading to various 
intracellular signaling cascades [154, 214, 215, 229].  These studies identified that IFF 
mechanotransduction occurs through glycocalyx heparan sulfate proteoglycans and focal 
adhesion FAK-ERK signaling, resulting in increased cell motility through increased MMP 
activity in 3D collagen gels [202].  Focal adhesion kinase (FAK) signaling to mitogen-
activated protein kinase (MAPK) has been observed to be involved in migration and 
differentiation in HCC [101].  It may be possible that glycocalyx-mediated IFF sensing in 
HCC could occur through signaling of FAK to MAPK activation resulting in increased cell 
motility.  This may be a potential mechanism since we observed MEK/ERK signaling, an 
important constituent in IFF-induced invasion in HCC, but could not identify any 
relationship to our CXCR4/CXCL12 results.  Additionally we observed CXCR4 inhibition 
with AMD3100 did not completely eliminate HCC-flow induced invasion (Figure 9A).  
CXCL12 could also act through an auxiliary receptor such as syndecan-4 (SDC-4), a 
transmembrane heparan sulfate proteoglycan that has been shown to regulate the migration 
response of HCC cells to CXCL12 gradients [276].  Alternatively, IFF could also induce 
invasion through mechanisms entirely independent of CXCR4/CXCL12.  Previous studies 
have shown that IFF stimulated upstream invasion (against the direction of flow) of breast 
cancer cells through activation of integrins and focal adhesion reorganization and 
polarization [214, 245].  Given the nature of our 3D flow invasion assay and study, we only 
measured downstream invasion; invasion in the opposite direction would not be captured 
by our transwell system.  Since the changes we observed resulted in increased invasion in 
the direction of IFF, we can also conclude that the mechanisms at play are likely separate 
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from any induction of upstream invasion, since we are explicitly not quantifying that 
component of the invasion response.    
In conclusion, we demonstrated that IFF is a critical factor in HCC invasion, and 
potentially drives invasion through two separate signaling pathways.  First, we show that 
HCC cells invade in response to IFF via a CXCR4/CXCL12-dependent mechanism.  Our 
findings suggest that this occurs through autologously generated pericellular gradients due 
to HCC cell-secreted CXCL12 and IFF, corroborating previous studies of the autologous 
chemotaxis mechanism [181, 209, 213, 235].  Second, we have evidence that the 
MEK/ERK pathway plays a critical role in IFF-induced HCC invasion, but one that is not 
downstream of CXCR4/CXCL12.  Our study provides a better understanding of how 
biomechanical forces like IFF can alter signaling pathways that drive HCC invasion, and 
may potentially provide a basis for investigating new therapeutic strategies for HCC.  
Ultimately, the goal is to reduce HCC invasion and prevent HCC from spreading 
intraphepatically or metastasizing to other organs.  We have shown some HCC cells 
become invasive upon exposure to this subtle fluid flow, and identifying these specific cells 
that respond strongly to flow could result in new therapeutic strategies to prevent invasion.  
Based on our study, it is evident that biomechanical forces such as IFF can affect HCC cell 
invasion.  However, in order to better understand the role of mechanical forces within the 
tumor microenvironment, the development of complex in vitro models is required along 
with a greater understanding of how cellular machinery is utilized to sense and react to 
these micro-environmental changes.   
 
 
 
 
67 
 
 
CHAPTER 3: MMP-2 AND MMP-9 ACTIVITY PROMOTES INTERSTITIAL 
FLOW-INDUCED INVASION OF HEPATOCELLULAR CARCINOMA CELLS  
 
3.1 Introduction 
 
 The poor prognosis for HCC patients is attributed to the difficulties in early 
detection and limited treatment options once diagnosed.  Consequently the World Health 
Organization has ranked HCC to be the second leading cause of cancer-related deaths 
worldwide.  The high mortality rate associated with liver cancer requires a greater 
fundamental and mechanistic understanding of hepatocyte transformation and tumor 
progression.  Traditional approaches for examining tumor cell behavior has often focused 
on investigating the various genetic components that have been dysregulated.  However, 
recent studies have shown the interactions between the tumor cells and surrounding 
microenvironment aid in HCC progression, tumor growth, and survival [44, 73, 90, 279].  
These findings have shifted the focus from systemic chemotherapies to the investigation 
and development of drugs that target tumor-stromal interactions in order to improve the 
overall survival of patients with advanced HCC [43].   
The dynamic interactions between tumor cells and their constantly evolving 
microenvironment has been observed to be a critical component for tumor progression.  A 
significant number of studies have shown that changes in biomechanical forces within the 
TME such as solid stresses [257], fluid pressure [146], and fluid flow [154, 214, 215, 218] 
alter cancer progression [223, 258].  Previous research has demonstrated that interstitial 
fluid flow (IFF), one of the biomechanical forces that is altered during tumor growth, can 
promote cancer cell invasion [209, 245], alter stromal fibroblast behavior [216], and 
increase MMP secretion [218]. 
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MMPs have been identified as key contributors to changes in the tumor 
microenvironment during cancer progression [130, 134].  To date, 23 human MMPs 
categorized by their architecture into 5 main subtypes have been identified. These zinc-
dependent endopeptidases are capable of modulating various cancer signaling pathways to 
promote cancer cell migration, invasion, survival, and ultimately cancer progression.  Of 
the 23 different human MMPs, we hypothesized specifically the gelatinase MMPs, MMP-
9 and MMP-2, are involved in flow-induced HCC invasion.  Recent literature has 
elucidated MMP-9 and MMP-2 in HCC to alter invasiveness of tumor cells along with 
variety of cell functions [280, 281].  MMP-9 secretion has been observed to be increased 
in HCC via the MEK/ERK, PI3K/Akt, PTEN, and NF-κB signaling pathways, resulting in 
increased cell migration and invasion [277, 278, 282, 283].  Inhibition of MMPs has been 
a therapeutic focus for various cancer types, including HCC, and has been shown to provide 
many anti-metastatic effects [281].  Therefore, the overall goal of this study was to 
elucidate the contribution of MMPs in IFF-induced HCC cell invasion.  We hypothesized 
that IFF would increase expression of MMP-9 and MMP-2, to promote flow-induced HCC 
invasion.  Our findings indicate IFF does not increase total protein expression of MMP-9 
and MMP-2, but instead enhances MMP-9 and MMP-2 activity promoting flow-induced 
HCC cell invasion.  For the first time we demonstrated that MMP-9 and MMP-2 are 
involved in flow-induced HCC invasion.   
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3.2 Methods 
 
Cell Culture 
Hepatoma-derived Huh7 were cultured in RPMI 1640 with L-glutamine (Cellgro, 
Manassas, VA) supplemented with 10% FBS (Atlanta Biologicals, Atlanta, GA) and 1% 
penicillin/streptomycin (Mediatech, Herndon, VA).  The Huh7 cells were maintained in a 
humidified 37˚C environment with 5% CO2.   
 
3D Interstitial Flow Invasion Assay  
The Huh7 cells (5.0 x 105 cells/ml gel) were encapsulated in a gel comprised of 1.3 
mg/ml rat tail tendon type I collagen (BD Biosciences, San Jose, CA) and 1 mg/ml Matrigel 
(BD Biosciences) and seeded into 12 mm diameter, 8 µm pore diameter culture inserts 
(Millipore, Bellerica, MA).  Static and flow conditions were generated over the course of 
24 hours by following a previously described method [209, 216, 267].  For the static 
condition, the level of basal medium outside of the transwell was level with the medium 
inside the transwell, resulting in little to no hydrostatic pressure difference.  The IFF 
condition was created by adding more basal medium to the inside of that transwell than the 
outside, resulting in a hydrostatic pressure difference of approximately 1 mm Hg.  This 
drove IFF through the collagen gel, with an average velocity of approximately 0.05 – 0.1 
µm/s (based on average volumetric flow rate and the cross-sectional area of the gel).  This 
velocity is on the lower end of velocities measured in or modeled for tumors, but much 
higher than the IFF velocities predicted for normal hepatic lobules [145, 146, 268].  Cells 
that transmigrated through the porous membrane were fixed with 4% paraformaldehyde 
(Sigma-Aldrich, St. Louis, MO) and stained with DAPI (2 µg/ml, MP Biomedicals, Santa 
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Ana, CA).  Fixed and stained cells were imaged by fluorescence microscopy.  Both static 
and flow conditions were analyzed by counting five locations on the fixed membranes.  
Percent invasion was calculated with the following equation: 
 
% -.#/01. = 2	345#64 7488 71).9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For specific experiments, pharmacological inhibitors were added to the cell/gel mixture 
before gel polymerization and in the media used for the experiment at their respective target 
concentrations.  For MMP inhibition, a pan-MMP inhibitor, GM6001 (50 μM) (EMD 
Millipore, Billerica, MA), was utilized in the 3D invasion assay.  SB-3CT (25 μM) 
(Selleckchem, Houston, TX) was utilized for specific MMP-2 and MMP-9 inhibition, as 
previously shown [284, 285].  Cell viability from the inhibitor treatments was quantified 
with the commercially available LIVE/DEAD cell viability assay (Molecular Probes, 
Eugene, OR) on Huh7 cells in 3D conditions.   
 
CXCL12 Chemotaxis Assay 
Huh7 cells (5.0 x 105 cells/ml gel) were added to the same type of gel and cell-
culture inserts used for the 3D flow invasion assay.  To determine if CXCL12 could 
stimulate invasion while inhibiting MMP-9 and MMP-2 the cells were exposed to a 
gradient of recombinant human CXCL12 (80 ng/ml) with or without SB-3CT (25 μM) 
added to the gel and/or medium.  Cells were placed in their respective treatment conditions 
for 24 hours at 37˚C with 5% CO2.  Cells that migrated through the membrane of the cell-
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culture insert were fixed and stained.  Invasion was quantified following the same method 
described for the 3D flow invasion assay.  
 
Enzyme-linked immunosorbent assay (ELISA) 
Cell lysates and basal medium were collected from Huh7 cells that were utilized 
for our 3D invasion assay.  First cells were digested out of the gels with collagenase D 
(0.5625 U/ml, Roche Life Science, Indianapolis, IN) for 45 minutes and then centrifuged 
for 10 minutes at 1,000 RPM.  Cells were lysed with RIPA buffer containing protease 
inhibitors.  Basal medium from their respective static or flow conditions was pooled 
together and concentrated using Amicon Ultra-15 centrifugal filter units (EMD Millipore, 
Billerica, MA).   MMP-9, MMP-2, TIMP-1, and TIMP-2 levels were quantified using a 
commercially available DuoSet ELISA kit (R&D Systems, Minneapolis, MN).  Standard 
curves were generated using known concentrations of the supplied recombinant human 
protein and data were fit with a four parameter logistic curve in MATLAB (MathWorks, 
Natick, MA).   
 
Gelatin Zymography of MMP-2 and MMP-9 Activity 
 Gelatinase activity was measured by performing electrophoresis of protease 
samples in denaturing and non-reducing conditions.  For 3D samples, cells were first 
digested out of the gels with collagenase D (0.5625 U/ml, Roche Life Science, 
Indianapolis, IN) for 45 minutes and then centrifuged for 10 minutes at 1,000 RPM.  Cells 
were lysed with RIPA buffer without any protease inhibitors.  A commercial protein 
quantification assay (Pierce BCA Protein Assay Kit, Thermo Fisher Scientific, Waltham, 
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MA) was utilized to quantify protein in order to better normalize the samples for the 
zymogram.  Samples were prepared in at a 1:1 ratio of 2X SDS loading buffer to lysate 
without any boiling.  Lysates were ran in non-reducing conditions on Novex 10% tris-
glycine zymogram gelatin gels (Thermo Fisher Scientific, Waltham, MA) with 1X tris-
glycine SDS run buffer.  Once completed, the gels were placed in 1X renaturing buffer 
(Thermo Fisher Scientific, Waltham, MA) for 30 minutes, followed by 1X developing 
buffer (Thermo Fisher Scientific, Waltham, MA) over night at 37ºC.  Zymogram gels were 
stained with SimplyBlue Safestain (Thermo Fisher Scientific, Waltham, MA) for 1 hour at 
room temperature.  Zymogram imaging was conducted with a FluorChem M imaging 
system (Proteinsimple, San Jose, California) and quantified with ImageJ 1.51 (National 
Institutes of Health (NIH), Bethesda, Maryland).  MMP activity levels were normalized to 
the respective matrix conditions and densitometry was used to determine fold change 
resulting from exposure to flow.   
 
Statistical Analysis 
All data are presented as mean ± SEM.  All results for invasion and chemotaxis 
assays are based on a minimum of two independent experiments with sample size n ≥ 3 for 
each experiment.  Statistical significance between two groups was determined by 
conducting a Student’s t-test.  For three or more groups, one or two-factor ANOVA with a 
Bonferroni or Tukey’s multiple comparison test was utilized.  GraphPad Prism 5 (San 
Diego, CA) was used to perform statistical analyses. 
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3.3 Results 
MMPs contribute to flow-induced HCC invasion 
 MMPs have been recognized as significant contributors to tumorigenesis, and they 
serve as major non-cellular modulators of the TME in various carcinomas.  These 
proteolytic enzymes are most often observed to contribute to the remodeling of the ECM, 
in turn promoting migration and invasion in most cancer types [57, 130, 198, 277, 283].  
Therefore, we hypothesized that MMPs could enhance IFF-induced HCC invasion.  To 
block MMP activity, GM6001 (50 μM) a broad spectrum MMP inhibitor, was incorporated 
into the 3D invasion assay.  The inhibition of MMPs with GM6001 resulted in a 3.2 fold 
decrease in flow-induced invasion (Figure 12A).  Furthermore to verify the concentration 
of GM6001 was not inflicting any cytotoxic effects on the Huh7 cells, a commercial cell 
viability assay was conducted on Huh7 cells and no significant cell death was observed 
(Figure 12B).  Our results indicate that MMPs could play a key role in flow-induced HCC 
invasion.   
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Figure 12: MMPs involved in flow-induced invasion.  (A) GM6001 (50 μM), a broad 
spectrum MMP inhibitor reduces IFF-induced invasion in Huh7 cells. (n=12).  * = p < 
0.05 between each respective treatment condition.  # = p < 0.05 between static vs. flow 
conditions of the two treatments assessed by two-way ANOVA.  (B)  LIVE/DEAD cell 
viability assay conducted on Huh7 cells in a 3D conditions to determine cytotoxic effect of 
inhibitors and their chose concentrations.  (n = 3). 
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The gelatinase MMPs regulate flow-induced HCC invasion 
 
To specifically block MMP-9 and MMP-2 activity, SB-3CT (25 μM), a selective 
gelatinase inhibitor, was incorporated into the 3D invasion assay [284, 285].  This resulted 
in nearly a complete cessation of flow-induced invasion in the Huh7 cells (Figure 13A).  
Verification of cell viability of Huh7 cells treated with SB-3CT (25 μM) was conducted 
with a commercial LIVE/DEAD cell viability assay and confirmed no significant cell death 
from the inhibitor treatment (Figure 13B).  Overall these findings implicate MMP-9 and 
MMP-2 specifically as their inhibition results significant decrease in flow-induced 
invasion.   
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Figure 13: MMP-9 and MMP-2 inhibition significantly reduces IFF-induced Huh7 
invasion.  (A) SB-3CT (25 μM), specific inhibitor for the gelatinase MMPs, MMP-9 and 
MMP-2, significantly reduces IFF-induced invasion in Huh7 cells. (n=6).  * = p < 0.05 
between each respective treatment condition.  # = p < 0.05 between static vs. flow 
conditions of the two treatments assessed by two-way ANOVA.  (B)  LIVE/DEAD cell 
viability assay conducted on Huh7 cells in a 3D conditions to determine if there is a 
cytotoxic effect of the inhibitors at experimental concentrations.  (n=3). 
 
 
 
CXCL12-mediated chemotaxis is not affected by MMP-9 and MMP-2 inhibition 
 
 Our previous findings of autologous chemotaxis as mechanism for IFF-induced 
HCC invasion suggests that Huh7 cells secrete the chemokine CXCL12, and subsequent 
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transport by IFF generates a pericellular chemokine gradient [286].  Functional testing with 
a CXCL12 neutralizing antibody and oversaturation of the CXCR4 receptors with 
exogenous CXCL12 highlight the significance of this gradient component in the 
autologous chemotaxis mechanism [286] (Figure 10).  To determine if MMP-9 and MMP-
2 contribute to the autologous chemotaxis mechanism, we conducted a chemotaxis assay 
incorporating SB-3CT.  In the presence of a CXCL12 gradient (80 ng/ml), Huh7 cells were 
nearly 1.5 fold more invasive (Figure 14).  In the absence of CXCL12 with inhibition of 
MMP-9 and MMP-2, Huh7 cells were less migratory.  Simultaneously blocking MMP-9 
and MMP-2 with the presence of a CXCL12 gradient suggest that the Huh7 are capable of 
chemotaxis under MMP-9/2 inhibition.  Therefore, suggesting inhibition of MMP-9 and 
MMP-2 is not tied to our earlier findings of chemokine-dependent autologous chemotaxis.  
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Figure 14: Huh7 cells chemotact in response to CXCL12 irrespective of inhibition of 
MMP-9 and MMP-2.  Chemotaxis assay conducted on Huh7 cells in static environment 
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(n=15).  Exogenous CXCL12 – 80 ng/ml.  SB-3CT (25 μM).  Top or Bottom = location of 
CXCL12 or SB-3CT added to Boyden chamber.  Test condition: - = no exogenous 
CXCL12 present; CXCL12 = exogenous CXCL12 added; SB-3CT = SB-3CT added; and 
SB-3CT/CXCL12 = both exogenous CXCL12 and SB-3CT added.  Invasion results 
normalized to control condition with no exogenous CXCL12 or SB-3CT.  * = p < 0.05 
between respective conditions. 
 
 
 
IFF does not modulate MMP-9 and MMP-2 protein levels 
 
IFF has been shown to upregulate MMP protein levels by shear stress sensing via 
the glycocalyx in various cell types such as metastatic renal carcinoma cells, fibroblasts, 
vascular smooth muscle cells, myofibroblasts, and dermal fibroblasts co-cultured with 
tumor cells [172, 184, 216-218].  Here we hypothesized that IFF-induced HCC invasion 
was a result of increased MMP expression and secretion resulting in degradation of the 
ECM to promote invasion.  Therefore we quantified the expression and secretion of MMP-
9 and MMP-2 with via ELISA.  Cell lysates and basal medium (concentrated) from our 3D 
invasion assay were collected to quantify the amount of secreted MMP-2 and MMP-9 
representing intracellular and cell-associated MMP levels.  Our results indicate that IFF 
does not alter the intracellular/cell-associated expression or secretion of either MMP-9 or 
MMP-2 (Figure 15).  Notably, the overall amount of MMP-2 is nearly 100X greater than 
MMP-9 in the cell lysates and basal medium (Figure 15B).      
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Figure 15: IFF does not alter MMP-9 or MMP-2 expression or secretion Huh7 cells.  
(A) Average MMP-9 expression in 3D cell lysates and basal medium (concentrated) 
collected from 3D invasion assay (lysate and medium, n=3).  n.s. = no significant 
difference.  (B)  Average MMP-2 expression in 3D cell lysates and basal medium 
(concentrated) collected from 3D invasion assay (lysate and medium, n=3).  n.s. = no 
significant difference.   
 
 
 
IFF increases MMP-9 and MMP-2 activity 
 
 A variety of MMPs and their inhibitors are often expressed in the TME, however 
their respective activation or inhibition is quite complex.  The local balance of these MMPs 
with their respective inhibitors is a determining factor in net MMP activity and may 
ultimately affect tumor progression.  The expression of these MMPs have been observed 
in a variety of carcinomas, but more important is their activation.  Recently mechanical 
forces in the TME have been shown to be regulatory factors in MMP activity by promoting 
proteolytic degradation of the ECM [287, 288].  Therefore, we investigated the effects of 
IFF on MMP-9 and MMP-2 activity by gelatin zymography.  Cell lysates and media 
(supernatants) were collected from Huh7 cells exposed to IFF.  Zymogram results indicate 
that cell lysates from Huh7 cells exposed to IFF have greater MMP-9 and MMP-2 activity 
compared to their static counterparts (Figure 16A).  A noticeable increase in both the latent 
(pro form) and active form of both MMPs is observed for cells exposed to IFF; nearly a 
1.4 fold increase in MMP-9 and 2.3 fold increase in MMP-2 activity (Figure 16C).  
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Conversely, IFF did not increase MMP-2 or MMP-9 activity from the concentrated media 
samples.  However a noticeable difference was observed in the presence of pro-MMP-2 
compared to its active form, but there was no difference between static vs. flow conditions 
(Figure 16B and D).  Overall these results indicate that IFF does not increase expression 
of MMP-9 and MMP-2, but does enhances MMP-9 and MMP-2 activity in cell lysates, 
which in turn may increase invasion of cells exposed to IFF.   
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Figure 16: Exposure to IFF results in greater MMP activity in Huh7 cells.  (A)  
Representative gelatin zymogram of MMP-9 and MMP-2 activity in Huh7 cells exposed 
to IFF (n = 6).  Pro-MMP-9 = 92 kDa, active-MMP-9 = 87 kDa, pro-MMP-2 = 72 kDa, 
and active-MMP-2 = 66 kDa.  (B) Representative gelatin zymogram of MMP-9 and MMP-
2 activity from concentrated basal medium (n = 2).  Pro-MMP-9 = 92 kDa, active-MMP-9 
= 87 kDa, pro-MMP-2 = 72 kDa, and active-MMP-2 = 66 kDa.  (C) Densitometry of 
zymogram results of the cell lysate samples (n = 6).  Combined average relative fold change 
of total MMP activity (static vs. flow).  Sum of pixel density of flow condition (pro-MMP 
+ active-MMP) divided by the sum of pixel density of respective static condition (pro-
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MMP + active-MMP).  Averaged for each zymogram.  * = p < 0.05, one sample T test.  
(D) Densitometry of zymogram results of concentrated basal medium samples (n = 2).  
Combined average relative fold change of total MMP activity (static vs. flow).  Sum of 
pixel density of flow condition (pro-MMP + active-MMP) divided by the sum of pixel 
density of respective static condition (pro-MMP + active-MMP). Averaged for each 
zymogram.  
 
 
 
IFF does not alter TIMP levels to promote flow-induced HCC invasion 
 
 Tumor and stromal cells secrete MMPs promoting tumor cell invasion from the 
increased enzymatic activity.  Proteolytic activity of MMPs is inhibited by tissue inhibitors 
of metalloproteinases (TIMPs) at a 1:1 ratio of TIMP to active MMP.  This balance of 
MMPs to TIMPs is important in regulating remodeling of the ECM architecture.  
Therefore, we examined the TIMP-1 and TIMP-2 levels in Huh7 cells exposed to IFF.  We 
determined that TIMP-1 levels from the cell lysate and concentrated medium did not 
change in cells exposed to IFF (Figure 17A).  There was no significant difference in TIMP-
2 levels between the two conditions in either the cell lysate or concentrated medium (Figure 
17B).  However, it was noted that there was a significant difference in TIMP-2 levels 
between the concentrated medium and cell lysate for Huh7 cells exposed to IFF (Figure 
17B).  These findings suggest that the IFF-induced increase in MMP-2 and MMP-9 activity 
is not due to modulation of TIMP-1 and TIMP-2 levels in response to IFF.  
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Figure 17: TIMP-1 and TIMP-2 expression in Huh7 cells and respective medium.  (A) 
Average TIMP-1 expression in 3D cell lysates and basal medium (concentrated) collected 
from 3D invasion assay (lysate and medium, n=2).  n.s. = no significant difference.  (B) 
Average TIMP-2 expression in 3D cell lysates and basal medium (concentrated) collected 
from 3D invasion assay (lysate and medium, n=3).  n.s. = no significant difference.  # = p 
< 0.05 between lysate and concentrated basal medium from the flow condition assessed by 
two-way ANOVA.   
 
 
 
3.4 Discussion 
 
 In this study we uncovered that IFF is capable of increasing MMP-9 and MMP-2 
activity in Huh7 cells.  These findings suggest that MMP-9 and MMP-2 are necessary and 
play an integral role in IFF-induced HCC invasion, but are not directly involved in the 
previously elucidated autologous chemotaxis mechanism [286], as Huh7 cells treated with 
a selective MMP-9 and MMP-2 inhibitor are still invasive in the presence of an exogenous 
CXCL12 gradient.  Furthermore, these findings also indicate the expression levels of either 
MMP-9 or MMP-2 cannot be correlated to flow-induced invasion, rather the MMP activity 
is enhanced when cells are exposed to IFF.  Finally, natural inhibitors of activated MMPs, 
both TIMP-1 and TIMP-2 levels are not altered due to IFF.  These findings suggest that 
IFF disturbs the balance of MMPs and TIMPs, as TIMP-1 nor TIMP-2 are increased to 
mitigate the imbalance of ECM enzymes.  These results ultimately highlight the importance 
of MMP-9 and MMP-2 in HCC flow-induced invasion and provides the basis for another 
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potential mechanism that may regulate IFF-induced invasion or effect a cells ability to 
invade.  
 MMPs were not of much interest to researchers until the 1960s when they were 
observed to be upregulated in inflammatory diseases like rheumatoid arthritis and cancer.  
MMPs have been observed to play a critical role in cancer; primarily they are known for 
their roles in ECM remodeling [289].  In pathological cases like fibrosis, the balance of 
MMPs to their natural inhibitors, TIMPs, is crucial in regulating matrix production and 
degradation.  These zinc-dependent endopeptidases play a critical role in the TME and 
promote HCC tumorigenesis by modulating various cancer signaling pathways [130].  
Recently, mechanical forces in the TME have been shown to be regulatory factors in MMP 
activity by promoting proteolytic degradation of the ECM [287, 288].  Shear stress 
generated by IFF has been shown to directly upregulate MMPs in glioma cells promoting 
cell motility and ultimately tumor progression [218].  IFF has been shown to induce 
differentiation in fibroblast and increase MMP secretion, which indirectly promotes tumor 
cell migration via matrix priming [216, 221].   
 Our current results indicate that IFF does not increase MMP-9 or MMP-2 
expression in HCC cells, but rather increases activity of these MMPs (Figure 15).  These 
findings differ from some of the current literature that has shown exposure to fluid flow 
shear stresses on glioma cells resulted in decreased MMP-2 expression and in rat aortic 
smooth muscle cells suppressed MMP-2 activity, but upregulated MMP-1, reducing 
migration [172, 218, 290].  Tarbell and colleagues have proposed a mechanism with 
heparan sulfate proteoglycan-mediated FAK activation is responsible for flow-induced 
mechanotransduction.  In this mechanism, MMP expression is increased via IFF that is 
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sensed by the components of the glycocalyx and transduced into a biochemical signal in 
turn activating the FAK-ERK-c-Jun signaling axis to promote vascular cell motility [198, 
202].  While our findings do not match up with some of Tarbell and colleagues work, it is 
important to note the significant differences in experimental set up, length of fluid flow 
exposure, and observation of MMP activity.  The Darcy flow experimental apparatus 
possesses constant hydrostatic pressure to drive fluid flow, generating shear stress on the 
cells which is substantially different than the 3D flow invasion assay our experiments 
utilized.  The use of Boyden chambers is a commonality that is observed for the 3D in vitro 
conditions in both this and Tarbell’s experimental set-up; however, the incubation periods 
for the cell/gel suspensions and length/magnitude of flow exposure vary tremendously.  
The Boyden chambers are decoupled from the Darcy flow apparatus and incubated in a 
static environment with medium containing a chemoattractant for 48 hour and eventually 
cell migration and protein expression are quantified [218].  This is substantially different 
from the 3D invasion assay set up utilized in this study as cell invasion, protein expression, 
and activity were quantified immediately after 24 hours exposure to IFF to determine 
specifically the effects of IFF.  Gel compaction and cell viability were not of concern as 
they were in the Tarbell study due to the magnitude of shear stresses that were applied.  
Thus explaining the differences in our findings and suggesting proteolytic activity of 
MMPs is specific and in response to IFF.     
Recent HCC studies have implicated specifically MMP-9 and MMP-2 to alter 
invasiveness of tumor cells along with variety of cell functions [280, 281].  A noteworthy 
difference that was observed in this study was the difference in MMP levels in the Huh7 
cells; nearly 100X more MMP-2 compared to MMP-9.  This elevated level of MMP-2 is 
83 
 
 
also observed in humans with fibrosis, which could correspond to the high levels we 
observed since most HCCs develop in underlying cases of chronic liver injury [291].  Many 
studies have shown that stromal cells are the major source of MMPs, which could explain 
why we did not observe increased levels of MMP in our single cell system [130].  Our 
major finding in this study was the difference in MMP-9 and MMP-2 activity in cells 
exposed to IFF (Figure 16).  Notably, we observed increased pro and active forms of both 
MMPs in Huh7 cells exposed to IFF.  This increased activity is not due to the presence of 
more MMP nor TIMP expression.  The increased MMP-9 and MMP-2 activity could be 
due to the localization of MMPs on the cell surface in response to IFF.  Future studies are 
required to examine the effects of the SB-3CT inhibitor on MMP-2 and MMP-9 activity 
levels via gelatin zymography; this would further confirm the role of these two MMPs in 
flow-induced invasion and validate the specificity of the inhibitor.  Alternatively, MMP-
2/9 have the potential to promote HCC cell invasion from the release of growth factors, 
cytokines, and angiogenic factors from proteolytic processing of ECM proteins [292-294].  
Additionally, extracellular proteolysis can activate or inactivate cell surface receptors such 
as cytokines, chemokines, and growth factors.  The processing of these cell surface proteins 
can cause intracellular signal transduction triggering irreversible changes to tumor cell 
behavior by altering cell growth, survival, migration, and invasion; ultimately resulting in 
disease progression [130, 294, 295].  Utilizing antibodies for specific cell surface receptors 
with IF/ICC techniques and fluorescent microscopy, future studies would quantify changes 
to these surface receptors in wildtype and MMP knockdown HCC cells.  Standard ELISA 
assays could accurately quantify the release of various growth factors and cytokines into 
the ECM post-proteolysis.  Localization or compartmentalization of MMPs triggers an 
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imbalance in MMP: TIMP ratio, and the presence of IFF could generate a gradient of 
soluble factors that activate the MMPs.  Additionally TIMP-2 possesses unique 
characteristics as it is observed to be both an MMP inhibitor and activator of MMP-2 at 
low to moderate levels.  We observed such levels of TIMP-2 in the concentrated medium 
which could explain the significantly high MMP-2 levels.  Notably, Qazi and Tarbell, 
observed increased MMP-1 and MMP-2 activity in highly metastatic renal carcinoma cells 
and the upregulation of these MMPs and cell adhesion molecules was mediated by the 
glycocalyx components which ultimately regulated flow-enhanced migration [217].  
Further investigation into components that regulate cell adhesion such as integrins and E-
cadherin are essential to determine the effect of IFF on cell invasion and MMP-9/-2 
activity.   
In this study we determined MMP-2/9 to play a critical role in flow-induced HCC 
invasion as the activity of the gelatinases increased with IFF exposure.  However the 
outstanding question that remains is how IFF is increasing MMP-2/9 activity in the Huh7 
cells.  One likely candidate would be the transmembrane MMP, MT1-MMP, which has 
been shown to activate various pro-MMPs via pro-MMP-2/13 activation, which results in 
the cleavage of various ECM proteins [296, 297].  MT1-MMP also plays a crucial role in 
maintaining ECM turnover of various collagens, fibronectin, laminin, and even 
proteoglycan; however, it plays a crucial role in the progression of various cancer types, 
including HCC [298-300].  In HCC, MT1-MMP has been observed to play a critical role 
in intrahepatic spread by promoting cell survival while playing a prominent role in matrix 
degradation to increase invasion [301].  MT1-MMP is one potential lead worth 
investigating in the 3D fluid flow assay considering the significantly elevated levels of 
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MMP-2 that were detected in this study.  Based on our initial findings of MMP-2 levels, I 
hypothesize that MT1-MMP would be upregulated in HCC cells exposed of IFF via MMP-
2, further enhancing HCC invasion.  Profiling and quantifying RNA expression of MT1-
MMP along with western blotting to determine expression levels under fluid flow would 
provide a foundational understanding regarding this membrane MMP.  Alternatively, it is 
well known that ECM proteolysis can result in the release of bioactive compounds that can 
activate the latent gelatinases.  Thrombin and activated protein C have been observed to be 
activators for pro-MMP-2, while plasmin, trypsin, and activated MMP-2/3/13 can activate 
pro-MMP-9 [294, 295].  Therefore, future studies would quantify the levels of these 
compounds in the presence of IFF to determine if bioavailability and bioactivity is altered 
in the presence of fluid flow resulting in increased MMP-2/9 activity.   
 Previously, we demonstrated CXCR4/CXCL12 mediated autologous chemotaxis 
as a mechanism for flow-induced invasion.  One of the major components of this 
mechanism is the presence of a CXCL12 gradient that is detected by the HCC cells.  
Utilizing a chemotaxis assay, we observed Huh7 cells were still invasive even when MMP-
9 and MMP-2 signaling was inhibited.  These findings show that MMP-9 and MMP-2 were 
not involved in the elucidated autologous chemotaxis mechanism, but played a separate 
role in flow-induced invasion.  Future studies are required to investigate the various 
signaling pathways that may be involved in this increased MMP-9 and MMP-2 activity.  
MMP secretion has been observed to be increased in HCC via the MEK/ERK, PI3K/Akt, 
PTEN, and NF-κB signaling pathways, resulting in increased cell migration and invasion 
[277, 278, 282, 283].  These studies could be conducted with the 3D flow assay and with 
western blot, we could determine signaling pathways that are involved.  Identifying a 
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relationship with any of these signaling pathways and increased MMP-9/2 activity in 
response to IFF could result in an effective therapeutic strategy to limit HCC cell invasion 
and metastasis. 
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CHAPTER 4: THE SYNERGISTIC RELATIONSHIP BETWEEN 
INTERSTITIAL FLUID FLOW AND MATRIX STIFFNESS ON 
HEPATOCELLULAR CARCINOMA INVASION 
 
4.1 Introduction 
 
Uncontrollable tumor progression and intrahepatic metastasis serve as the main 
causes of death in HCC patients.  Notably patients with HCC often have an underlying 
chronic liver disease which plays a pivotal role in the development of HCC.  In the presence 
of HBV, HCV, non-alcoholic fatty liver disease (NAFLD), or the more severe form of 
NAFLD, non-alcoholic steatohepatitis (NASH), chronic liver injury and inflammation is 
present and over time these events result in fibrosis and cirrhosis of the liver, often 
progressing to HCC [7, 9, 47].  More than 80% of HCCs occur in patients who suffer from 
chronic fibrosis or cirrhosis where inflammation and the hepatic wound-healing response 
contributes to hepatocarcinogenesis [302].  Chronic liver injury promotes changes in the 
hepatic architecture most notably with the formation of fibrotic scars and subsequently 
increasing matrix stiffness [303-305].   
The remodeling of the ECM has been highlighted as a critical component in 
tumorigenesis and the spread of these tumor cells to distant tissues.  The accumulation of 
type I collagen and fibronectin together plays an integral part in the mechanical strength of 
the interstitial matrix [306].  In a variety of cancer types, it has been observed that the 
increase in matrix stiffness is a result of tumor growth, which can disturb the mechanical 
forces and biochemical signaling that occurs in the microenvironment, effectively 
promoting disease progression [304, 307-310].  Similar results have been observed in HCC 
from the increase in matrix stiffness and clinically this increase in stiffness has served as a 
predictor for HCC development [79, 101, 257, 277, 303, 311, 312].  While increased matrix 
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stiffness serves as a good indicator of cancer progression and growth, more importantly the 
synergistic changes in mechanical forces and signaling pathways and there interactions in 
this microenvironment stimulate invasion.  With such a unique disease profile and risk 
factors, many studies have examined the effects of stiffness in a static form on HCC 
progression.  To date, there are no studies that examine the effect of IFF on HCC cells in a 
stiff matrix microenvironment.  We previously highlighted some key signaling pathways 
(MEK/ERK), proteolytic enzymes (MMP-9/MMP-2), and elucidated a mechanism 
(autologous chemotaxis via CXCR4/CXCL12) involved in HCC flow-induced invasion.  
We hypothesize that HCC cells in a fibrotic microenvironment exposed to IFF will result 
in increased CXCL12 secretion, enabling autologous chemotaxis to promote greater flow-
induced invasion.  In this chapter we will highlight the synergistic relationship of increased 
matrix stiffness and flow-induced invasion.   
 
 
4.2 Methods 
 
Cell Culture 
Hepatoma-derived Huh7 were cultured in RPMI 1640 with L-glutamine (Cellgro, 
Manassas, VA) supplemented with 10% FBS (Atlanta Biologicals, Atlanta, GA) and 1% 
penicillin/streptomycin (Mediatech, Herndon, VA).  The Huh7 cells were maintained in a 
humidified 37˚C environment with 5% CO2.   
 
Non-enzymatic Glycation of Collagen 
 In order to examine the effects of matrix stiffness and IFF on HCC cells, the first 
objective was to develop a method to increase the stiffness of the collagen/Matrigel matrix 
89 
 
 
for the 3D invasion assay that would not hinder the HCC cells ability to invade.  Non-
enzymatic pre-glycation was utilized as a method to increase the stiffness of the 
collagen/Matrigel matrix [313, 314].  First the rat tail tendon type I collagen (BD 
Biosciences, San Jose, CA) was pre-glycated with 250 mM D-ribose (Acros Organics, 
Geel, Belgium) diluted in 0.1% acetic acid for 5 days at 4ºC.  After the 5 day incubation in 
250mM D-ribose the pre-glycated collagen with Matrigel was utilized for the 3D invasion 
assay.   
 
Rheological Analysis of Collagen Gels  
 Rheometry was utilized to validate that non-enzymatic glycation of collagen 
increased the stiffness of collagen gels.  The rheological analysis was conducted on the 
Discovery Hybrid Rheometer 3 (DHR-3) (TA Instruments, New Castle, DE) using a 25 
mm parallel plate geometry. To validate the pre-glycation method, three collagen 
conditions were compared: normal stock collagen, pre-glycated collagen with 250 mM D-
ribose in 0.1% acetic acid incubated for 5 days at 4ºC, and collagen with 250mM D-ribose 
in 0.1% acetic acid added the same day.  The three collagen/Matrigel acellular gels were 
prepared in the same manner and concentration as they were prepared in the 3D interstitial 
flow invasion assay and incubated on the platens at 37ºC for 30 minutes to polymerize 
before rheological analysis.  A solvent trap was utilized during polymerization of the gels 
to minimize any dehydration.  Upon polymerization, the solvent trap was removed before 
any rheological analysis.  An initial set of amplitude sweeps with an angular frequency of 
1, 10, and 100 rad/s were conducted in order to determine linear viscoelastic region of the 
gels to assess proper testing.  Oscillation frequency sweeps from 0.1 – 100 rad/s were 
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performed at 1% strain determined from the initial amplitude sweeps.  The shear storage 
modulus (G’) of each gel condition was calculated using the resulting stress and strain data 
and the following equation: 
GH = cos	L $M& 
L = Nℎ#/4 #.684;   = /ℎ4#5 /954//;  M = /ℎ4#5 /95#0.  
Stiffness of the three collagen gel conditions were reflected by changes in G’.  Four 
experiments were conducted to validate the pre-glycation method with corresponding 3D 
interstitial flow invasion assays to examine the effects of stiffness and fluid flow.  Shear 
storage moduli results are presented with +/- standard deviation and average shear storage 
moduli values are reported based on the average values over a frequency range of 0.25 – 
39.8 rad/s.   
 
3D Interstitial Flow Invasion Assay  
The Huh7 cells (5.0 x 105 cells/ml gel) were encapsulated in a gel comprised of 1.3 
mg/ml rat tail tendon type I collagen (BD Biosciences, San Jose, CA) and 1 mg/ml Matrigel 
(BD Biosciences) and seeded into 12 mm diameter, 8 µm pore diameter culture inserts 
(Millipore, Bellerica, MA) for normal matrix conditions.  To expose the Huh7 cells to a 
stiff matrix, rat tail tendon type I collagen was pre-glycated for 5 days at 4ºC with 250mM 
d-ribose in 0.1% acetic acid and was utilized with Matrigel at the respective concentrations 
mentioned previously.  The pre-glycated gel with the Huh7 were seeded into the 12 mm 
diameter, 8 µm pore diameter culture inserts.  To validate and confirm the pre-glycation 
method with 5 day collagen and ribose incubation increased stiffness, a third gel condition 
with collagen treated with 250 mM D-ribose in 0.1% acetic acid added the same day was 
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incorporated (denoted in results as ‘same day’ condition).  Once the three gel conditions 
polymerized, encapsulating the cells in either a normal or stiff matrix, the 8 µm pore 
diameter culture inserts were placed in basal medium for a 40 minute incubation 37ºC to 
allow residual D-ribose to diffuse out, ameliorating the effects of un-glycated sugar on 
HuH7 cell invasion.  This incubation was done to both the pre-glycated matrix and normal 
matrix to ensure consistent experimental conditions.  Static and flow conditions were 
generated over the course of 24 hours by following a previously described method [209, 
216, 267].  For the static condition, the level of basal medium outside of the transwell was 
level with the medium inside the transwell, resulting in little to no hydrostatic pressure 
difference.  The IFF condition was created by adding more basal medium to the inside of 
that transwell than the outside, resulting in a hydrostatic pressure difference of 
approximately 1 mm Hg.  Cells that transmigrated through the porous membrane were 
fixed with 4% paraformaldehyde (Sigma-Aldrich, St. Louis, MO) and stained with DAPI 
(2 µg/ml, MP Biomedicals, Santa Ana, CA).  Fixed and stained cells were imaged by 
fluorescence microscopy.  Both static and flow conditions were analyzed by counting five 
locations on the fixed membranes.  Percent invasion was calculated with the following 
equation: 
 
% -.#/01. = 2	345#64 7488 71).9 ∗ 	;4<=5#.4 /)5>#74 #54#	-<#64 #54# ∗ 	?)<=45 1> 7488/ /44@4@ A ∗ 100 
 
For specific experiments, pharmacological inhibitors were added to the cell/gel mixture 
before gel polymerization and in the media used for the experiment at their respective target 
concentrations.  AMD3100 (12.6 μM) (R&D Systems, Minneapolis, MN) was utilized for 
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CXCR4 inhibition.  SB-3CT (25 μM) (Selleckchem, Houston, TX) was utilized for MMP-
2/MMP-9 inhibition.   
 
 
Western Blot 
Western blot was used to measure changes in total and phosphorylated protein 
levels in response to IFF and specific inhibitors.  Cells were lysed with RIPA buffer 
containing Halt protease and phosphatase inhibitor cocktail (Thermo Scientific, Waltham, 
MA).  For 3D samples, cells were first digested out of the gels with collagenase D (0.5625 
U/ml, Roche Life Science, Indianapolis, IN) for 45 minutes and then centrifuged for 10 
minutes at 1,000 RPM.  The following primary antibodies were used to detect the proteins 
of interest:  anti-CXCR4 (1:1,000, Abcam, Cambridge, England), anti-MMP-2 (1:1000, 
Abcam, Cambridge, England), anti-MMP-9 (1:1000, Abcam, Cambridge, England), and β-
actin (13E5) (1:2,000, Cell Signaling Technology, Beverly, MA).  The following 
secondary antibody was used: goat anti-rabbit IgG-HRP (1:10,000, Abcam, Cambridge, 
England), and anti-rabbit IgG (1:2,000, Cell Signaling Technology, Beverly, MA).  
Chemiluminescence imaging was conducted with a FluorChem M imaging system 
(Proteinsimple, San Jose, California) and quantified with ImageJ 1.51 (National Institutes 
of Health (NIH), Bethesda, Maryland).  Target protein levels were normalized to β-actin. 
 
Enzyme-linked immunosorbent assay (ELISA) 
Protein from 3D cell lysates and medium were collected from Huh7 cells in static 
varying matrix stiffness conditions after a 24 hour incubation at 37˚C and 5% CO2.  
Protease inhibitors were added to all cell lysates and media.  CXCL12 levels were 
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quantified using a commercially available DuoSet ELISA kit (R&D Systems, Minneapolis, 
MN).  Standard curves were generated using known concentrations of recombinant human 
CXCL12 and data were fit with a four parameter logistic curve in MATLAB (MathWorks, 
Natick, MA).   
 
Gelatin Zymography of MMP-2 and MMP-9 Activity 
 Gelatinase MMP activity was measured by performing electrophoresis of protease 
samples in denaturing and non-reducing conditions.  For 3D samples, cells were first 
digested out of the gels with collagenase D (0.5625 U/ml, Roche Life Science, 
Indianapolis, IN) for 45 minutes and then centrifuged for 10 minutes at 1,000 RPM.  Cells 
were lysed with RIPA buffer without any protease inhibitors.  A commercial protein 
quantification assay (Pierce BCA Protein Assay Kit, Thermo Fisher Scientific, Waltham, 
MA) was utilized to quantify protein in order to better normalize the samples for the 
zymogram.  Samples were prepared in at a 1:1 ratio of 2X SDS loading buffer to lysate 
without any boiling.  Lysates were ran in non-reducing conditions on Novex 10% tris-
glycine zymogram gelatin gels (Thermo Fisher Scientific, Waltham, MA) with 1X tris-
glycine SDS run buffer.  Once completed, the gels were placed in 1X renaturing buffer 
(Thermo Fisher Scientific, Waltham, MA) for 30 minutes, followed by 1X developing 
buffer (Thermo Fisher Scientific, Waltham, MA) over night at 37ºC.  Zymogram gels were 
stained with SimplyBlue Safestain (Thermo Fisher Scientific, Waltham, MA) for 1 hour at 
room temperature.  Zymogram imaging was conducted with a FluorChem M imaging 
system (Proteinsimple, San Jose, California) and quantified with ImageJ 1.51 (National 
Institutes of Health (NIH), Bethesda, Maryland).  MMP activity levels were normalized to 
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the respective matrix conditions and densitometry was used to determine fold change 
resulting from exposure to flow.   
 
Statistical Analysis 
All data are presented as mean ± SEM.  All results for invasion assays are based on 
a minimum of two independent experiments with sample size n ≥ 3 for each experiment.  
Statistical significance between two groups was determined by conducting a Student’s t-
test.  For three or more groups, one or two-factor analysis of variance (ANOVA) with a 
Bonferroni or Tukey’s multiple comparison test was utilized.  GraphPad Prism 5 (San 
Diego, CA) was used to perform statistical analyses. 
 
 
4.3 Results 
 
Pre-glycation of collagen increases the stiffness of collagen gels 
 
 In this study, we utilized non-enzymatic glycation as a method to increase the 
stiffness of our polymerized gels, which encapsulate the HCC cells in the 3D flow assay.  
Glycation and increased proteoglycan levels are two methods for non-enzymatic collagen 
cross-linking [315-317].  Glycation, utilizing sugars like D-ribose, promotes collagen 
cross-linking and ultimately results in a stiff matrix compared to a non-glycated one.  Pre- 
and post-glycation have both been observed to increase hydrogel stiffness, however pre-
glycation results in a greater accumulation of Amadori intermediates to aid in the formation 
of advanced glycation end products (AGEs) which have been shown to increase 
mechanical properties of hydrogels [313, 314].  Upon pre-glycating our collagen for 5 days 
at 4˚C with 250 mM D-ribose, we prepared normal, ribose added same day, and preglycated 
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collagen gels at the same concentration as gels used in the 3D invasion assay.  After 
polymerization, rheological analysis for the shear storage modulus was completed by 
running frequency sweeps on the 3 gels.  The pre-glycated gels possessed an average shear 
storage moduli that was more than four times greater than the normal gels (Figure 18A).  
Average shear storage modulus and standard deviation were calculated from the linear 
region of the frequency sweeps (0.25 – 39.8 rad/s) for each gel (Figure 18B).  The pre-
glycated gels possessed statistically significant greater shear moduli compared to the 
normal or same day conditions.  Further statistical analysis also confirmed that there was 
no statistical difference between the ribose added same day to the collagen or the normal 
collagen hydrogel, which signifies the glycation process is essential and requires the 5 day 
incubation to allow for increased stiffness.  The rheological analysis confirmed that pre-
glycation of collagen with 250 mM D-ribose is an acceptable method for increasing the 
stiffness of the gels utilized in the 3D invasion assay [318].   
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Figure 18:  Pre-glycation as a method for increasing hydrogel stiffness.  (A) Shear 
storage moduli of varying collagen treatments from rheological analysis.  Error bars 
represent standard error of mean.  (B) Average shear storage moduli of linear region from 
the frequency sweeps for the varying gel conditions.  Error bars represent SEM.  Statistical 
significance between gel conditions determined by one-way analysis of variance with 
Bonferroni’s multiple comparison test.  * = p < 0.05.  n.s. = no significant difference.   
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Multiplicative increase in flow-induced HCC invasion in a stiff matrix 
 
 Once we were able to validate our method to increase the stiffness of our 
collagen/matrigel matrix, the next step involved observing the effects of both flow and 
stiffness on HCC cell invasion.  Huh7 cells in the pre-glycated matrix exposed to flow 
invaded significantly higher than the cells in the normal or same day condition (Figure 
19A).  Furthermore, it was important to note that the Huh7 cells in the matrix with ribose 
added the same day and the normal matrix had comparable flow-induced invasion 
percentages, confirming that the ribose itself was not responsible for the increase cell 
invasion  (Figure 19A).  Corresponding stiffness values were identified from the respective 
collagen conditions via rheometry (Figure 19B).  The increased stiffness and exposure to 
fluid flow ultimately resulted in a nonlinear increase in cellular invasion providing us with 
compelling evidence of a synergistic relationship between these two forces.  The 
synergistic relationship between IFF and matrix stiffness on HCC invasion was confirmed 
by conducting a two way ANOVA with a Bonferroni posttest.  The statistical analysis 
determined the interaction between a stiff matrix and IFF-induced invasion was 
significantly different and there is only a 0.56% chance of randomly observing such an 
interaction.  A synergistic relationship is observed when an effect arising between two 
factors results in an effect that is observed to be greater than the sum of their respective 
individual effects.  Thus, our results indicated the combination of matrix stiffness and IFF 
resulted on HCC cell invasion was greater than the sum of these individual factors.       
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Figure 19: Increased matrix stiffness results in a multiplicative increase of flow-
induced HCC cell invasion.  (A) Percentage of Huh7 cells that invaded in response to 
fluid flow in a normal or stiff matrix.  Increased stiffness denoted in the pre-glycated matrix 
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condition.  Control matrix to validate stiffness and the ribose had no external effect on 
invasion was represented by the same day matrix condition.  Normal and Pre-glycated 
matrix, n=12 (static and flow); Same day matrix, n=9 (static and flow).  Error bars represent 
standard error of mean.  * = p < 0.05 between static vs. flow of respective matrix condition.  
# = p < 0.05 between static vs. flow condition of the three matrix conditions assessed by a 
two-way analysis of variance and Bonferroni’s multiple comparison test.  (B)  
Representation of average percentage of Huh7 cells that invaded vs. shear storage moduli 
of corresponding matrix condition.  Normal and Pre-glycated matrix, n=9 (static and flow); 
Same day matrix, n=6 (static and flow).  Error bars represent standard error of mean 
(horizontal error bars = shear storage modulus standard error of mean; vertical error bars = 
% invasion standard error of mean).  
 
 
 
 The synergistic effect of matrix stiffness on IFF-induced cell invasion is not mediated 
through CXCR4 or CXCL12 
  
Our previous work elucidated autologous chemotaxis via CXCR4/CXCL12 as one 
mechanism for flow-induced HCC cell invasion.  Therefore, we investigated the 
components in autologous chemotaxis, CXCR4 and CXCL12, in a stiff matrix.  First we 
observed if CXCR4 expression in a Huh7 cells within a stiff matrix changed.  The Huh7 
cells were encapsulated in the varying matrix stiffness conditions without the presence of 
flow for 24 hours and digested out of their respective gels and lysed.  Western blot results 
revealed no significant change in expression of CXCR4 irrespective of the matrix the Huh7 
cells were in (Figure 20A).  Based on initial gel densitometry analysis of the western blot, 
there was a decrease in CXCR4 expression in Huh7 cells encapsulated in a stiff matrix 
(Figure 20A) compared to cells in a normal matrix.  Additionally, after utilizing AMD3100, 
a pharmacological inhibitor for CXCR4, in a 3D interstitial flow assay with pre-glycated 
matrix, there was much lower functional response to the inhibitor compared to Huh7 cells 
in a normal matrix (Figure 20B).   
There was only a 1.3 fold decrease in flow-induced invasion in Huh7 cells in the 
pre-glycated matrix, and this effect caused by matrix stiffness is still measurable even after 
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inhibition of CXCR4 suggesting that matrix stiffness is not affecting IFF-induced invasion 
by modulating receptor levels or binding to CXCL12 (Figure 20B).  However, it is 
important to realize that autologous chemotaxis does not require the increase in expression 
of the receptor to be an effective mechanism of flow-induced invasion.  Therefore, the next 
step was to investigate the expression and secretion of the ligand in a stiff matrix.  Again 
Huh7 cells were encapsulated in a 3D static gels in various matrix conditions for 24 hours.  
Upon digestion of their matrix, cells were lysed and media collected from each respective 
condition.  A commercial CXCL12 ELISA kit was utilized to quantify ligand production 
and secretion from the Huh7 cells.  Ultimately there was no significant change in CXCL12 
production or secretion in either of the matrix conditions (Figure 20C).  In conclusion, our 
results indicate that matrix stiffness itself has a distinct effect on Huh7 invasion 
independent of CXCR4/CXCL12 signaling.   
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Figure 20: HCC cells in the presence of a stiff matrix does not alter components 
elucidated in the CXCR4/CXCL12 autologous chemotaxis mechanism.  (A)  CXCR4 
detection in Huh7 cells in 3D static gels with varying stiffness and quantitative western 
blot analysis.  CXCR4 = 43 kDa.  Percentage relative density compared to loading control 
for each lysate and normalized to the normal matrix condition.  (B) CXCR4 antagonist 
AMD3100 (12.6 μM) inhibits IFF-induced invasion less effectively in Huh7 cells in pre-
glycated matrix (n = 9).  N-UT = normal matrix untreated, N-AMD = normal matrix with 
AMD3100, PG-UT = pre-glycated matrix untreated, PG-AMD = pre-glycated matrix with 
AMD3100.     Error bars represent standard error of mean.  * = p < 0.05 between static vs. 
flow of respective matrix condition.  # = p < 0.05 between flow conditions of the treatment 
groups in respective matrix condition assessed by a two-way analysis of variance and 
Bonferroni’s multiple comparison test.  (C) Average CXCL12 expression in Huh7 cells in 
3D static with varying matrix conditions with ELISA.  Sample type: (n = cell lysate/n = 
medium) – (n=4).  
 
Evaluation of MMP-2 and MMP-9 in Huh7 cells in a stiff matrix exposed to interstitial 
fluid flow 
 The previous chapter highlights the significance of proteolytic enzymes like MMPs 
in HCC cell invasion.  Additionally many studies have highlighted the critical role MMPs 
play in the TME aiding in disease progression and metastatic spread [130, 134, 136] .  Their 
role is just as important in liver fibrosis, as MMPs and their inhibitors, TIMPs, create a 
positive feedback loop of collagen deposition due to their imbalance [50].  Based on our 
findings in Chapter 3, we identified that MMP-2 and MMP-9 are likely involved in IFF-
induced invasion of HCC cells.  Therefore we tested the selective inhibitor for MMP-9 and 
MMP-2, SB-3CT (25 μM), in varying matrix conditions.  We observed a significant 
decrease in flow-induced HCC cell invasion in both normal and pre-glycated matrix 
conditions treated with the inhibitor SB-3CT (Figure 21A).  These inhibitor results 
provided some early evidence that stiffness could enhance invasion in response to IFF via 
MMP-9 and MMP-2.  Next we investigated the expression of MMP-9 and MMP-2 in 
varying matrix conditions to determine if any significant changes could be attributed to 
stiffness.  However, no significant change in MMP-9 or MMP-2 expression was observed 
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in relation to matrix stiffness (Figure 21B).  MMP-9 and MMP-2 are also known as 
gelatinases, and they are often activated from various mechanical stimuli and soluble 
factors in the liver microenvironment [136-138, 291].  The expression of these activated 
MMPs by hepatoma cells is observed to significantly promote stromal invasion [319].  
Gelatin zymography was utilized to examine MMP-9 and MMP-2 activity in the presence 
of flow with varying matrix conditions.  IFF independently increased both latent and active 
forms of both MMP-9 and MMP-2, irrespective of matrix condition (Figure 21C).  
However stiffness alone did not result in in greater MMP-9 or MMP-2 activity, confirmed 
by densitometry (Figure 21D).  In conclusion these findings highlight the significance in 
the synergistic relationship between HCC flow-induced invasion in the presence of 
increased matrix stiffness, and MMPs play a critical role in the flow-sensing aspect for the 
increased invasion.   
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Figure 21: Examining the effects of increased stiffness and fluid flow on MMP-9 and 
MMP-2.  (A)  SB-3CT (25 μM), a selective inhibitor for MMP-9 and MMP-2 inhibits IFF-
induced HCC invasion independent of matrix condition.  (n = 12).  N-D = normal matrix 
with DMSO control, N-SB = normal matrix with SB-3CT, PG-D = pre-glycated matrix 
with DMSO, PG-SB = pre-glycated matrix with SB-3CT.* = p < 0.05 between static vs. 
flow of respective matrix condition.  # = p < 0.05 between flow conditions of the treatment 
groups in respective matrix condition assessed by a two-way analysis of variance and 
Bonferroni’s multiple comparison test.  (B)  MMP-9 and MMP-2 expression in Huh7 cells 
encapsulated in 3D static gels with varying matrix stiffness.  MMP-9 = 92 kDa and MMP-
2 = 72 kDa.  (C)  Representative gelatin zymogram of MMP-9 and MMP-2 activity in 
Huh7 cells exposed to IFF in stiff matrix conditions.  (n = 3).  Static 3D sample, (-) and 
Flow 3D Sample, (+).  Pro-MMP-9 = 92 kDa, active-MMP-9 = 87 kDa, pro-MMP-2 = 72 
kDa, and active-MMP-2 = 66 kDa.  (D)  Densitometry of zymogram results.  Combined 
average relative fold change of total MMP activity (static vs. flow conditions) for 
respective matrix condition.  Sum of pixel density of flow condition (pro-MMP + active-
MMP) divided by the sum of pixel density of respective static condition (pro-MMP + 
active-MMP).  Averaged for each zymogram for respective matrix condition. (n = 3).   
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4.4 Discussion 
 
 For the first time, we investigated the interaction between interstitial flow and 
increased matrix stiffness and their combined effects on HCC cell invasion.  Fibrosis and 
cirrhosis of the liver have been investigated extensively; ECM deposition is a hallmark for 
these events and results in increased matrix stiffness.  The increase in tumor and 
surrounding tissue stiffness has been observed in many different malignant tumors [320].  
Additionally the mechanisms and soluble factors involved in tumor-associated fibrosis are 
also involved in fibrosis from chronic liver injury [321, 322].   
In order to investigate the effects of matrix stiffness with the presence of IFF on 
HCC cells, we were tasked with first developing a method to increase matrix stiffness, 
without hindering the flow properties or exposing the HCC cells to cytotoxic 
chemicals/cross-linkers.  A potential method that could be utilized is simply increasing the 
concentration of the collagen to obtain increased stiffness.  However, there are a few 
significant drawbacks to this method such the resulting gel would possess increased ligand 
binding sites and increased cross-linking would result in the decrease of pore size from 
what is normally observed.  A more viable alternative is non-enzymatic glycation of the 
collagen gel which has been shown to control the stiffness of the gels without affecting 
collagen fibril mesh size or significantly increasing ligand binding sites while maintaining 
high cell viability [313, 314, 323].  ECM stiffness increases over decades for individuals 
with chronic liver injury triggering ECM deposition, thus the pre-glycation method was an 
ideal for increasing the stiffness of our hydrogels without altering the flow properties.   
There have been many studies that have investigated ECM stiffness of liver tissue 
under varying pathological conditions; magnetic resonance elastography of normal liver 
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tissue has measured values of Young’s modulus (E) of 300-600 Pa, while fibrotic and 
cirrhotic livers (depending on progression) can range from 1,500-20,000 Pa [324, 325].  It 
is crucial to point out that our measurements are of collagen (normal vs. preglycated) 
matrices and most measurements for diseased livers are conducted on rat or human liver 
tissue.  However recent rheology measurements conducted on decellularized liver tissue 
(normal vs. fibrotic) observed approximate storage moduli of ~40 Pa for normal 
decellularized liver tissue and 100-125 Pa for fibrotic decellularized liver tissue [318].  
These results are comparable to our rheology measurements from normal and preglycated 
acellular gels, suggesting cells in our model system are experiencing comparable matrix 
stiffness values to what they would see in vivo (Figure 18).   
After identifying a feasible method that would allow us to generate an in vitro 
environment simulating a stiff matrix and IFF, the next objective was to expose Huh7 cells 
to these mechanical forces.  Huh7 cells in a stiff 3D matrix (G’ ~ 115 Pa) and exposed to 
IFF were observed to be 3-fold more invasive than cells exposed to IFF in a softer 
environment (G’ ~ 27 Pa) (Figure 19A).  Similarly, the cells in a stiff static gel were also 
much more invasive compared to the cells in a normal matrix, but stiffness alone was not 
responsible for the multiplicative increase in invasion in the presence of IFF (Figure 19A).  
Stiffness and IFF had a multiplicative effect on invasion and together these results highlight 
the need for more studies that investigate multiple mechanical forces and their potential 
role in disease progression.  An outstanding question that remains in this study is 
determining if the effect of preglycating the collagen matrix on invasion is due solely to 
the increased stiffness.  Particularly, preglycation of the collagen results in the formation 
of AGE cross-links which alter the chemical composition of the matrix [326, 327].  
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Mechanosensitive cells, like endothelial cells, possess receptors for advanced glycation end 
products (RAGE) which are capable of interacting with the AGE cross-links in the glycated 
collagen matrix.  The AGE/RAGE interaction consequently results in changes in cell 
behavior and their ability to sense shear stress, cyclic stretch, and barrier function [328-
330].  Kemeny and colleagues investigated the diminished FAK activation due to the 
interactions with the glycated matrix and saw decreased Rho-GTPase signaling which in 
turn inhibited cytoskeletal changes in endothelial cells [328].  The same group further 
investigated the response of endothelial cells in a glycated matrix to cyclic strain and 
observed diminished integrin binding, activation, or lack of clustering of these 
mechanosensors, which inhibits FAK activation [329].  Furthermore, preliminary findings 
have stated that cells exposed to IFF can sense fluid drag-induced matrix tension and 
respond via increased integrin and FAK activation [214].  For this reason it is particularly 
important to determine the effects of pre-glycation on invasion due to increased stiffness 
and not due to the chemistry of the glycated matrix or the impairment in 
mechanotransduction of IFF in the HCC cells.   
Under those circumstances, examining the chemistry of the glycated matrix by 
investigating the AGE/RAGE interaction in our system would be an ideal starting point by 
inhibiting RAGE from binding to AGE with a RAGE antagonist such as FPS-ZM1.  
However, it is important to note that RAGE inhibitors are not completely specific in 
blocking the RAGE/AGE interaction and are capable of altering various cellular functions 
[331].  Additionally, the use of specific antibodies for blocking RAGE is an alternative 
measure to inhibit the RAGE/AGE interaction, but this would only be a viable and feasible 
option for short term functional testing as long term use of blocking antibodies would 
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become ineffective and the receptor would localize back to the surface of the cell [331].  
Investigating the RAGE/AGE interaction would be a straight forward way of examining 
the effects of flow-induced invasion in a pre-glycated matrix are impairing 
mechanotransduction of IFF, but until specific RAGE inhibitors and blocking antibodies 
are developed that do not possess the negative affects discussed previously, an alternative 
method of examining these mechanical stimuli is required.   
Glycation has been observed to enhance collagen crosslinking and change fibril 
assembly of type I collagen, as a result causes alterations in integrin binding site 
accessibility which in turn can prevent clustering and activation of integrins [332, 333].  
For the purpose of determining the effects on invasion are solely due to stiffness, 
independent of the chemistry of glycated collagen; the use of mixed synthetic and natural 
hydrogels would provide control of the mechanical properties.  Hydrogel matrices 
composed of collagen with varying concentrations of poly(ethylene glycol) di-(succinic 
acid N-hydroxysuccinimidyl ester) have been utilized to investigate HCC cell malignancy 
while providing control of matrix stiffness and limited changes to matrix permeability and 
chemical cues [334].  Examining HCC cells in a stiff matrix for integrin clustering, FAK 
activation, and tracking migration rates would allow for identifying the role stiffness on 
invasion.  Regulating any of the signaling components with specific antibodies or inhibitors 
in flow conditions would verify the contribution of stiffness on invasion.   
 Next we investigated if stiffness-induced signaling had any effect on the 
mechanisms of IFF-induced HCC invasion that we have previously described in Chapter 2 
with CXCR4/CXCL12 and Chapter 3 with MMP-2/9.  These results indicated that neither 
CXCR4 nor CXCL12 are changed in the presence of a stiff matrix (Figure 20).  Rather 
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there was a decreased response to AMD3100 for Huh7 cells exposed to IFF in a stiff matrix 
compared to cells in a normal matrix (Figure 20A).  Correspondingly, our results indicated 
that stiffness did not alter CXCL12 secretion by Huh7 cells (Figure 20C).  With this in 
mind, it must be noted that in vivo activated HSCs in a fibrotic environment are known to 
secrete CXCL12, resulting in HCC cell migration and metastasis [260, 335, 336].  
Additionally we examined no change in expression level of MMP-2 and MMP-9 in the 
various matrix conditions in HCC cells encapsulated in a 3D static gel (Figure 21B).  
Similarly there was no difference in MMP-2/9 activity levels in HCC cells exposed to IFF 
in either the normal matrix condition or the stiff matrix (Figure 21C).  Ultimately it appears 
that autologous chemotaxis applies to flow-induced HCC invasion while stiffness 
contributes to the invasion via another sensory mechanism such as glycocalyx shear stress 
sensing or integrin clustering.  These results show that MMPs are more likely to be 
implicated in flow-induced invasion as opposed to directly contributing to the invasion 
from stiffness. 
Our findings further suggest that HCC cells are mechanosensitive to their 
environments and adapt their responses to biomechanical changes.  The findings in this 
chapter suggest that another mechanism could be involved in flow-induced invasion, as we 
observed the effects of stiffness to be independent of autologous chemotaxis.  We know 
that IFF can create drag forces on matrix fibers found on the extracellular matrix generating 
high shear stresses on these fibers which can be transmitted to engaged integrin receptors 
[154].  In addition, integrins have been observed to be clustered on stiff substrates, thus 
IFF could potentially generate significantly high tension forces on these integrins resulting 
in increased migration and activation of various downstream signaling such as FAK 
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activation [337, 338].  With this in mind, it is important to note that the glycocalyx is 
capable of sensing shear stress resulting in changes to focal adhesion kinase (FAK), and 
extracellular signal-related kinase (ERK) [202, 203].  However non-enzymatic glycation 
of type I collagen has been observed to diminish collagen-proteoglycan binding and 
weaken cell adhesion [339].  Therefore, this current modified assay would not be an ideal 
method to examine glycocalyx shear stress sensing as a mechanism for IFF-induced 
invasion in a stiff matrix.  Provided that, I hypothesize increased integrin clustering 
presence in HCC cells embedded in a stiff matrix and with the presence of IFF results in 
increased focal adhesion turn over and activation promoting invasion.  Changes in integrin 
expression and clustering can be determined with fluorescence-activated cell sorting 
analysis to further conclude the effects of matrix stiffness on these mechanosensors.  
Furthermore, additional work could aid in determining if IFF alters localization of integrin 
clustering or activation via IF/ICC in HCC cells in a stiff matrix condition.  It is important 
to note that upstream migration has been observed in cells exposed to fluid flow with 
resultant tension forces, but our experimental set up does not examine migration upstream 
and notably the described study was not conducted in the context of a stiff matrix [245].  
Functional testing by inhibiting various families of integrins would allow us to determine 
which subclass is more responsive to IFF, but careful consideration of the experimental 
conditions would be required as inhibiting total cell adhesion could result in an 
experimental condition that would not be valid or desired.  Next observing downstream 
signaling components such as focal adhesion kinase and its crosstalk with Rho GTPase 
would be ideal.  I hypothesized due to increased integrin clustering, matrix tension will be 
significantly increased on cells in a stiff matrix exposed to IFF in turn resulting in 
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phosphorylation of FAK and increased Rho GTPase activity.  By modulating these 
signaling components, this would provide a better understanding of their role in flow-
induced invasion.  Examining the mechanosensory components in a stiff matrix could 
result in further elucidation of another mechanism for IFF-induced HCC invasion to 
corroborate the findings in this chapter. 
Matrix stiffness has been shown to modulate HCC cell proliferation, 
chemotherapeutic response, and even migration [340].  Migration through dense 3D ECM 
is only possible when the cell generates enough traction forces which are then transmitted 
through the cell-ECM adhesion components to displace itself from the matrix [341].  
Increased matrix stiffness is directly implicated in enhancing cellular contractility by 
changes in intracellular tension that is experienced by the cell from forces caused by 
contracting in respect to the elastic resistance by the stiff ECM [237].  For example, 
contractile forces have been shown to be increased in breast cancer cells in stiff 3D collagen 
matrices enhancing cell invasion [342].  Actin-myosin contraction inhibition has been 
shown to directly stop cell migration through a 3D matrix; this contraction and cytoskeletal 
change is regulated by Rho/ROCK signaling pathway.  ROCK signaling critically for cell 
migration in response to matrix stiffness, as it is capable of enhancing actin-myosin 
contractility and downstream substrates such as LIM-kinase and myosin light chain 2 
which also aid in cytoskeletal reorganization and promote migration [343-345].  
Rho/ROCK are particularly important clinically HCC; overexpression of RhoA in patients 
with HCC are likely to have greater chances of tumor reoccurrence and lower overall 
disease free survival [346].  Interestingly, a recent study has demonstrated that contact 
guidance by collagen alignment is particularly important via Rho/ROCK pathway for cell 
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migration and this matrix reorganization is more dependent on the initial contractility 
[347].  Furthermore, IFF increases contractile forces which in turn can alter cytoskeletal 
organization to promote tumor cell invasion.  In addition, Rho-mediated fibroblast 
contractility has been shown to enhance tumor cell invasion with IFF [216].  Therefore, 
examining the Rho-ROCK signaling pathway and determining any cytoskeletal changes 
from IFF exposure in a stiff matrix environment could elucidate a different mechanism 
corroborating the findings in this chapter.  ROCK is known to be a direct effect of RhoA, 
inhibiting ROCK with Y27632 would provide a method to determine the functional 
involvement of the Rho-ROCK signaling pathway.  Further investigation of the 
components of Rho-ROCK signaling, such as actin reorganization, focal adhesion 
formation, and myosin activity would be assessed with the inhibitor to verify the signaling 
generated by the IFF and/or a stiff matrix.  Examining the effects of IFF on cell contractility 
via ROCK activity can be further verified by utilizing a kinase activity assay.  For the first 
time we have investigated and identified the synergistic relationship between matrix 
stiffness and IFF on HCC cell invasion.  The preliminary findings in this chapter highlight 
the significant role IFF has on tumor cell invasion, but also exposes the dearth of 
knowledge and lack of mechanistic understanding we have regarding this subtle fluid flow.        
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CHAPTER 5: CONCLUSIONS AND FUTURE WORK 
 
5.1 Major Findings and Signficance 
 
Introduction 
 The findings from this dissertation establish a foundation for studying the effects 
of IFF on HCC cell invasion.  This research provides a multi-mechanistic understanding of 
flow-induced HCC invasion by identifying key signaling pathways that cause HCC cells 
to be more invasive when exposed to this subtle fluid flow.  The approach taken in this 
research examines the direct effect of IFF on HCC cells in a 3D microenvironment unlike 
many of the current and previous work that has been published.  HCC often develops in 
the presence of chronic liver injury which promotes changes to the hepatic architecture 
resulting in altered biomechanical forces such as increased matrix stiffness in the liver 
microenvironment.  This study establishes the development and validation of a 3D in vitro 
method to examine the synergistic effects of matrix stiffness and IFF on HCC cell invasion 
(Chapter 4).  For the first time this work carefully examines the effects of IFF on HCC 
invasion and shows how different mechanisms can govern HCC cell response to fluid 
flow.  The major findings of this study are (A) the IFF-induced invasion response of 
HCC cells occurs through multiple mechanisms and (B) there is a synergistic 
relationship between flow-induced HCC invasion in the presence of a stiff matrix. 
 
(A)  HCC cells are capable of invading in response to IFF through multiple 
mechanisms.   
• Autologous chemotaxis as a mechanism for HCC invasion occurs through the 
CXCR4/CXCL12 signaling axis.  This work carefully identifies that there is no 
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change in the expression or secretion of these chemokines, but rather IFF is 
capable of generating a biased chemoattractant gradient in the direction of fluid 
flow.   
• MEK/ERK signaling is required for IFF-induced HCC cell invasion but does 
not occur upstream or downstream of the elucidated CXCR4/CXCL12 
autologous chemotaxis.   
• IFF enhances MMP-9 and MMP-2 activity, independent of chemokine-
dependent autologous chemotaxis.  This flow-induced enhancement of MMP-
2/-9 activity occurs without any changes in MMP or TIMP expression. 
(B) The second major finding from this study highlights the synergy in flow-induced 
invasion in the presence of a stiff matrix 
• Matrix stiffness and IFF synergistically promotes HCC invasion independent 
of the previously elucidated CXCR4/CXCL12 autologous chemotaxis 
mechanism. 
• IFF independently increased MMP-9 and MMP-2 activity irrespective of the 
matrix condition.   
 
Prior understanding of IFF-induced mechanisms 
        Prior to the findings in this study, it was hypothesized that IFF increased cellular 
invasion through autologous gradient formation of chemokines that promote migration; 
this mechanism was coined, ‘autologous chemotaxis’.  Previous studies showed breast 
cancer cell lines exhibited increased invasion in the direction of IFF through a CCR7 
dependent mechanism while glioma cells were more invasive through a CXCR4-dependent 
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autologous chemotaxis mechanism [209, 235].   The findings in this study show that HCC 
cells are capable of sensing transcellular gradients of CXCL12 corroborating with the 
findings observed in flow-induced glioma invasion.  However, autologous chemotaxis is 
not the only mechanism observed in flow-induced invasion, which was observed in our 
findings as inhibition of the CXCR4 receptor did not completely diminish flow-induced 
invasion. 
        The mechanisms of IFF mechanosensing have not been fully identified and the 
formation of autologous transcellular gradients is only one mechanism that HCC cells may 
use to sense and respond to IFF.  The findings in this study identified the involvement of 
MEK/ERK signaling to be critical in flow-induced HCC invasion.  However the presence 
of elevated MEK/ERK signaling did not function through the CXCR4/CXCL12 signaling 
axis, suggesting the possibility of other mechanisms being simultaneously 
involved.  Another mechanism that has been identified in IFF sensing is glycocalyx shear 
stress sensing, where flow-induced stresses are transduced into and transmitted as solid 
stresses through core proteins of the glycocalyx, leading to various intracellular signaling 
cascades [154, 214, 215, 229].  Glycocalyx shear stress sensing could be argued as a 
potential mechanism for explaining the MEK/ERK involvement identified in this study as 
ERK1/2 was upregulated when exposed to fluid flow shear stresses in smooth muscle cells 
[202].  However, it is important to note the significant difference in experimental set up of 
fluid flow exposure compared to our gravity driven fluid-flow assay, as our hydrostatic 
pressure is not maintained at a constant amount for extensive periods of time.  Additionally 
experimental set up utilized in this body of work examines strictly the effects of fluid flow 
on the various signaling pathways immediately after the HCC cells are exposed to fluid 
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flow.  Tarbell and colleagues also showed ERK1/2 was activated in a non-tumor cell line 
after exposure to shear stress generated by fluid flow, which was different from the findings 
in this research as there was no observable difference in ERK1/2 with flow, but it was 
required for chemotaxis.       
Additionally, this study identified an increase in MMP-2/9 activity in Huh7 cells 
exposed to IFF, but not an increase in MMP-2/9 expression.  These findings do not align 
with some of the current literature that has shown exposure to fluid flow shear stresses on 
U087 and CNS-1 glioma cells resulted in downregulated MMP-2 expression and in rat 
aortic smooth muscle cells suppressed MMP-2 activity, but upregulated MMP-1 reducing 
migration [172, 218, 290].  The findings in this dissertation possess many differences from 
the findings in Tarbell and colleagues work, it is important to note the significant difference 
in experimental set up, length of fluid flow exposure, and observation of MMP activity.  
First, the experimental set up for application of fluid flow is substantially different in the 
Tarbell studies as their Darcy Flow Experimental Apparatus generates constant hydrostatic 
pressure to drive fluid flow exposing cells to shear stress.  Upon completion of the exposure 
to shear stress in the Tarbell experimental set up, the Boyden chambers are incubated in a 
static environment with basal medium containing a chemoattractant where finally invasion 
and protein expression/activity are quantified [218].  The Darcy Flow Experimental 
Apparatus set-up is substantially different from the 3D invasion assay set up utilized in this 
dissertation where protein expression and activity were quantified immediately after 24 
hours of exposure to IFF; ultimately allowing us to isolate and determine specifically the 
effects of IFF.  Therefore the findings in this study could be due to difference in the flow 
model and time point for measuring protein activity suggesting proteolytic activity of 
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MMPs is specific and in response to IFF.  The MMP-2/9 activity results also appeared to 
function separately from the autologous chemotaxis mechanism previously identified, 
further strengthening the argument that cells are capable of sensing and responding to IFF 
through multiple mechanisms. 
 
Synergy of matrix stiffness and IFF on HCC cell invasion 
The synergy of IFF and matrix stiffness resulted in a multiplicative increase in flow-
induced HCC invasion.  However these findings had minimal mechanistic relation to the 
molecular pathways elucidated in prior chapters.  The findings in this study showed IFF 
increased MMP-9 and MMP-2 activity, independent of stiffness.  These results also 
indicated that the MMP-2/9 activity was independent from autologous chemotaxis via 
CXCR4/CXCL12 signaling.  Downregulation of total MMP-2 expression has been 
observed in glioma cells upon exposure to shear stress generated by IFF, while the active-
MMP-2 was upregulated, this only slightly contradicts the results in this study as it was 
observed IFF increase MMP-2 activity for both the pro and active forms.  The effect of IFF 
on HCC cells in a stiff matrix could result in increased matrix tension and contractile forces 
which could be amplified by mechanosensors such as integrins.  Matrix shear stress sensing 
and the presence of glycocalyx have been shown to regulate integrin clustering on the cell 
surface in the presence of a stiff matrix.  The drag forces experienced would be much higher 
and disturbing the balance of contractile force signaling pathways such as GTPase RhoA 
would result in cytoskeletal changes and even increased ERK and MMP regulation.  
Furthermore, studies have shown that ECM rigidity can influence HCC cell migration 
behavior.  These cells have been shown to interchange between mesenchymal and 
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amoeboid migration in response to the microenvironment.  Mesenchymal mode of cell 
migration in the HCC cells in a stiff and stably cross-linked matrix possessed enhanced 
MMP-2 activity and integrin β1 expression [348]. 
 
 
Conclusion 
 
 In conclusion, this study provides evidence supporting multiple mechanisms 
regulate flow-induced HCC invasion.  This body of work uncovers autologous chemotaxis 
via CXCR4/CXCL12 signaling as one mechanism for flow-induced HCC invasion and 
suggests MEK/ERK signaling and MMP-2/9 activity to be involved independent of 
chemokine signaling in flow-induced invasion.  Additionally, from this body of work we 
learn that IFF-induced invasion in the context of a stiff matrix results in a multiplicative 
increase in invasion, thus the combination of these TME changes play a significant role in 
HCC progression.  The findings in this research contribute directly to the field of tumor 
mechanobiology by establishing a basic fundamental and mechanistic understanding of 
how HCC cells respond to mechanical forces in the tumor microenvironment.  This 
research establishes the foundation for future studies investigating how mechanical forces 
can alter molecular factors in the tumor microenvironment to help promote tumor 
progression.   
 
5.2 Future Work 
 
 The findings from this research raise many new questions in regards to flow-
induced HCC invasion and how IFF may alter HCC spread.  Future work will emphasize 
two major areas to further advance the findings in this study: (1) Improving the 3D IFF 
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assay to further investigate autologous chemotaxis and (2) examining the other elucidated 
mechanisms of flow-induced invasion. 
 
5.2.1 Improving the 3D IFF assay to further investigate autologous chemotaxis 
 The motivation for improving the 3D IFF assay would allow for deeper 
investigation into the autologous chemotaxis mechanism and ultimately provide a better 
understanding of cells interacting with the tumor microenvironment cohesively promote 
flow-induced invasion.  Two main areas of the 3D in vitro fluid flow assay require further 
investigation to better mimic physiological conditions; (1A) quantification of IFF velocity 
in vivo and simulating those IFF velocities in the 3D in vitro assay, and (1B) incorporation 
of hepatic stellate cells with HCC tumor cells in 3D fluid flow assay.  The future work 
proposed is significantly important in investigating and furthering our understanding of 
autologous chemotaxis as a mechanism for flow-induced HCC invasion in a more 
physiological perspective.   
 
Quantification of in vivo IFF velocity and the replication of IFF in vitro  
First there is an initial need to determine accurate IFF velocities from in vivo human 
or rat HCCs to better simulate this fluid flow in our study.  One weakness in this study is 
the assumption of physiological IFF velocity in the liver; the basis for this study is 
conducted in the low velocity spectrum of IFF which is determined by computational 
modeling and simulations correlating IFP to IFF velocity.  Many computational and 
modeling studies have simulated IFF or IFP in various physiological states; however, there 
is a clear need to measure IFF velocity in both animal and human tumor models in the liver.  
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The quantification and replication of accurate velocities are particularly important in 
studying autologous gradient formation.  One major criteria for this mechanism is the 
formation of extracellular gradients by fluid flow that cells are capable of detecting.  
Models of interstitial flow and autocrine morphogen secretion of a single cell demonstrate 
that convective forces alone can establish transcellular autologous gradients which are 
biologically relevant at IFF velocities ranging from 0.12 - 6.0 µm/s, even if the Peclet 
number suggests that diffusion is the dominant mechanism of mass transport. If the 
secreted factor is a chemoattractant, these autologous gradients can drive directed cell 
migration via a mechanism called autologous chemotaxis [209, 235].  Furthermore, HCC 
often develops in the context of chronic liver injury resulting in changes to many 
biomechanical forces in the TME.  Examining fluid flow velocity in HCCs in the presence 
of fibrotic hepatic architecture could result in significantly different velocities altering 
convective mass transport.  With this in mind, in vivo IFF velocities have been observed to 
be significantly higher, ranging between 5 µm/s – 50 µm/s, which are much higher than 
the velocity observed in our 3D fluid flow assay [146, 147]. 
Examining and replicating in vivo IFF velocities and flow profiles would ultimately 
answer the following questions to help further our understanding of autologous 
chemotaxis: 
1) Are IFF velocities different in HCCs that arise in the context of chronic liver 
injury compared to primary HCCs? 
2) How do higher or in vivo IFF velocities alter mass transport or gradient 
formation?  Downstream formation?   
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3) How does IFF velocity affect receptor/ligand affinity and recycling of surface 
receptor?   
Having accurate IFF velocity values in a variety of HCC tumor stages would result in 
accurate in vitro testing conditions for understanding HCC invasion.  Furthermore, most 
HCC cases arise in the context of chronic liver injury, understanding the role of the 
morphological and architectural changes on IFF in a diseased liver would provide a range 
of physiologically relevant IFF velocities and fluid flow patterns utilized for future in vitro 
studies.  I hypothesize IFF velocity in a late stage HCC tumor is significantly higher than 
earlier stage HCCs.  Measuring IFF velocity can be accomplished by utilizing dynamic 
contrast-enhanced MRI (DCE-MRI) with gadolinium diethylene-triamine penta-acetic 
acid (Gd-DTPA contrast agents as described in the Hompland study [146].  Utilization of 
DCE-MRI with Gd-DTPA contrast agents would allow for a non-invasive method of 
measuring IFF velocity.  An alternative non-invasive options such as Doppler optical 
coherence tomography could be utilized in highly vascularized tumors as this method is 
capable of measuring flow velocity without contrast agents [349].  Utilization of 
computational fluid dynamics software such as COMSOL, it would be possible to 
determine the potential of gradients to form under relevant IFF velocities based on the 
hepatic architecture.  Examining the receptor and ligand components elucidated in Chapter 
2 along with their binding affinity would tell us how the HCC cells are invading due to the 
autologous chemotaxis mechanism, or if they are utilizing another flow-sensing 
mechanism.  One of the early findings in Chapter 2 identified a correlative increase in HCC 
cell invasion with respect to increased fluid flow velocity.  Profiling IFF velocity could 
lead to clinical applications or strategies to prevent intrahepatic spread.  
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HCC tumor cells co-cultured with hepatic stellate cells (HSCs) in the 3D fluid flow assay 
 The development of in vitro experimental systems that incorporate cellular 
components to better simulate pathological conditions observed in vivo, ultimately help 
advance our understanding of cellular events that occur and aid in uncovering the potential 
mechanisms involved.  In this body of work, the experimental set up examined directly the 
effect of IFF on the HCC tumor cells, however much evidence has indicated HCC cells 
and HSCs work in a bidirectional fashion as ‘partners in crime for liver metastases’ as 
described by Kang and colleagues [350].  In fact the development of HCC is often in the 
presence of underlying chronic liver injury such as fibrosis, and quiescent HSCs are 
activated by this repeated liver injury and various activators [75].  The incorporation of 
HSCs into the 3D fluid flow assay with HCC cells is not to simply add complexity to the 
in vitro assay, but rather examine their crosstalk on the autologous chemotaxis mechanism.  
With attention on HSCs as major contributors to HCC progression, these cells are capable 
in contributing to autologous chemotaxis via CXCR4/CXCL12, but also play a significant 
role in cellular contractility in stiff ECMs.   Upon activation, HSCs experience a phenotypic 
transformation where they increase proliferation, secretion of ECM proteins, production 
various cytokines, chemokines, and growth factors [46, 51, 52, 77, 78].   
With this in mind, the development of a valid co-culture of HSCs and HCC tumor 
cells will allow us to examine the elucidated CXCR4/CXCL12 autologous chemotaxis 
mechanism further in-depth.  Recent findings show SDF-1 (CXCL12) is released by 
activated HSCs within liver tumors resulting in liver metastasis of colon cancer cells which 
possess CXCR4 [351].  This brings into question whether IFF can activate latent HSCs 
resulting in CXCL12 secretion.  Consequently, stromal cells have been observed to be 
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express active TGF-β, which interacts with CXCR4.  Additionally TGF-β upregulates 
CXCR4 expression in HCC cells to ultimately sensitize them to the ligand CXCL12, 
resulting in increased tumor cell migration and survival [352].  For this reason, future work 
co-culturing HSCs with tumor cells in the 3D fluid flow assay has the potential to elucidate 
alternative flow-induced mechanisms.  Additionally this co-culture system would allow for 
further investigation of cell-to-cell and cell-to-ECM interactions allowing further 
investigation into the flow-induced invasion mechanisms elucidated earlier or 
hypothesized (contractility).   
Incorporating HSCs with the HCC tumor cells will require future testing and 
validation of the viability and quiescent state of the cells.  Verification of the HSCs’ 
inactive state can be determined with various microscopy techniques.  HSCs in a quiescent 
state will possess vitamin A lipid depositions and a stellate morphology.  Activated HSCs 
will no longer possess this stellate morphology, but rather an elongated cell body with 
visible reduction in vitamin A lipid depositions and express α-SMA.  One drawback to this 
method of microscopy is the thickness of the gel these cells are encapsulated in, therefore 
confocal microscopy could be utilized to examine the state of these cells.  Therefore, this 
new co-cultured 3D fluid flow assay could provide further insight into autologous 
chemotaxis via CXCR4/CXCL12 as a mechanism for flow-induced HCC invasion or help 
identify alternative mechanisms for flow-induced HCC invasion. 
 
5.2.2 Examining alternative mechanisms of flow-induced invasion  
One of the major findings in this body of work is the autologous chemotaxis 
mechanism for flow-induced HCC invasion described in Chapter 2.  However one major 
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consensus can be made from this body of work is that flow-induced HCC invasion is 
regulated by multiple mechanisms, which is apparent with our MMP-2/9 findings.  Future 
work will address the existing mechanisms for flow-induced invasion described in Chapter 
1 and elucidate various signaling pathways that are involved in this response to fluid flow.  
The motivation for this work has two major purposes: (1) elucidate the various components 
in signaling pathways involved in the other mechanisms that regulate flow-induced 
invasion and (2) determine if specific HCC cell types and their propensity to utilize a 
specific mechanism for flow-induced invasion or are all of the elucidated mechanisms 
simultaneously.  The purpose of uncovering all the mechanisms that regulate flow-induced 
HCC invasion would highlight the significance of biomechanical forces in tumor 
progression and show that these forces must be taken into consideration for therapeutic 
strategies.  For this reason, elucidating the factors that determine which mechanisms the 
cells’ use or specific cells prefer at certain stages of the disease could result in a therapy 
targeting the mechanisms in use for flow-induced invasion.   
The alternative mechanisms described in Chapter 1 for flow-induced invasion 
investigated and described shear stress sensing through the glycocalyx and matrix tension 
and integrin activation by IFF.  Shear stress sensing via the glycocalyx has been extensively 
studied by Tarbell and colleagues; furthermore, one of the seminal findings in this work is 
the increase in MMP-2/9 activity but not an increase in gelatinase expression.  Under those 
circumstances, investigating the matrix tension and integrin activation mechanism could 
be a logical avenue worth pursuing first.  I hypothesize that IFF exposure results in 
increased matrix tension and traction forces which triggers ECM proteolysis via MMP-2/9 
as a result releasing growth factors such as TGF-β and PDGF to increase cell invasion via 
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EMT.  Alternatively, ECM proteolysis via MMP-2/9 activity could alternatively degrade 
various cell surface receptors and diminish cell-matrix adhesions.  The basis for this 
mechanism is based on our initial findings of increased MMP-2/9 activity in HCC cells 
exposed to IFF.  A pivotal study by Zaman and colleagues showed that migration of tumor 
cells in 3D conditions is governed by ECM stiffness, cell-matrix adhesion, proteolysis 
[341].  Therefore the first major task that is required to elucidate this mechanism further is 
to determine if matrix tension or contractility are increased in HCC cells exposed to fluid 
flow.  Examining RhoA activity would confirm changes in contractile actin myosin 
filaments in response to IFF.  Alternatively, staining for FAK or integrin activation could 
serve as additional measures to confirm increased contractile forces are possible due to 
increased cell-matrix adhesions.  Next it has been shown that mechanical forces or external 
stimuli can cause proteolysis and specifically the degradation of ECM proteins can alter 
focal adhesion, cytoskeletal architecture, and even integrin-mediated anchorage [353].  Our 
current results state, IFF results in increased MMP-2/9 activity, therefore functional testing 
of the gelatinases and examining cell-matrix adhesions would tell us if proteolysis is 
directly affecting cellular adhesion.  If MMP-2/9 proteolysis is diminishing cell-ECM 
adhesion, the cell would not adhere to the collagen matrices they are embedded in and 
exposed to fluid flow.  Diminished cell-matrix adhesion via proteolysis would cause the 
cells to simply end up in the bottom of the 12 well plate and not attached to the bottom of 
the Boyden chamber.  Flow cytometry could be utilized to quantify the cells that did not 
adhere to the matrix.  In the event that cell-matrix adhesion was not completely diminished, 
quantification of growth factors such as TGF-β and PDGF via ELISA would be conducted 
first to test the hypothesis of invasion in response to IFF is facilitated by EMT.  These two 
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growth factors are found in the ECM in normal healthy livers as well as HCCs, and they 
are both capable of promoting EMT in HCC cells observed to facilitate increased invasion 
[354].  EMT can be confirmed with follow up experiments identifying EMT markers such 
as E-cadherin and functional inhibition of EMT should result in decreased invasion.  
Furthermore, elucidation of this mechanism would not identify if autologous chemotaxis 
was not completely involved.  Therefore, since it is already known that TGF-β can sensitize 
CXCR4 and promote CXCL12 binding enhancing migration.  Knocking down CXCR4 
would diminish the cells ability to detect a gradient of CXCL12, simultaneously promoting 
EMT and measuring cell invasion would determine the mechanism cells prefer to utilize 
for flow induced invasion.  Alternatively, exposing cells to IFF and isolating the cells that 
migrated through the matrix and to the bottom of the Boyden chamber could be probed for 
EMT markers to determine what mechanism a population of cells utilized.  Changing 
matrix conditions and repeating the previous experiments could yield in a different 
mechanistic preference for flow-induced invasion.   
In conclusion, this body of work uncovered that HCC cells utilize multiple 
mechanisms for flow-induced invasion.  The elucidation of autologous chemotaxis 
provided insight into one mechanism for flow-induced HCC invasion.  However the later 
findings in this body of work revealed how little is known about IFF and the mechanisms 
that regulate flow-induced invasion and the various components that are involved.  The 
current findings and future work could potentially provide a better understanding of which 
mechanism(s) these cells have a propensity to utilize under relevant physiological 
conditions.  Profiling of these cells or HCC stage, could provide better insight into clinical 
applications and strategies for treating HCC spread.   
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